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Validity of dietary glycemic load as a predictor
of postprandial glycemia and insulinemia in
lean, young healthy adults
J BAO1, F ATKINSON1, P PETOCZ2, W WILLETT3,
J BRAND-MILLER1
1Boden Institute of Obesity, Nutrition & Exercise, the University
of Sydney, Sydney, Australia; 2Department of Statistics,
Macquarie University, Sydney, Australia; 3Harvard School of
Public Health, Harvard University, USA
Background: The concept of dietary glycemic load (GL, defined as
the mathematical product of the glycemic index (GI) and carbohy-
drate content of a serving of food) is increasingly used in nutritional
epidemiology. Its ability to predict postprandial glycemia and insuli-
nemia for a wide range of foods or mixed meals is unclear.
Objective: To determine the degree of association between calculated
GL and glucose and insulin responses in healthy subjects consuming
iso-energetic portions of single foods and meals.
Design: In study one, groups of healthy subjects consumed 1000 kJ
portions of 121 single foods in 10 food categories. In study two,
healthy volunteers consumed 2000 kJ of 13 mixed meals. Foods and
meals varied widely in macronutrient content, fibre and GL. Glyce-
mia and insulinemia were quantified as incremental area under the
curve relative to a reference food (=100).
Outcomes: GL was the strongest predictor of the observed glucose
and insulin responses induced by single foods (r = 0.92 and 0.77
respectively, both P < 0.001), accounting for 84% and 59% of the
variation in glucose and insulin responses respectively. For mixed
meals, responses varied over a five-fold range and were strongly cor-
related with GL (r = 0.76, P = 0.002 for glucose and r = 0.68,
P = 0.01 for insulin). In contrast, macronutrients and fibre were not
significant predictors of either response.
Conclusion: The findings provide robust support for the physiological
validity of GL in predicting both postprandial glycemia and insulin
demand to a wide variety of foods and meals.
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Cut-off value of 50 g glucose challenge test for
the diagnosis of gestational diabetes mellitus
D BORIBOONHIRUNSARN, T LERTBUNNAPHONG,
P KHANMALI
Department of Obstetrics and Gynecology, Faculty of Medicine,
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Objective: To determine the cut-off value of 50 g glucose challenge
test (GCT) for the diagnosis of gestational diabetes mellitus (GDM)
among Thai pregnant women.
Materials and Methods: A total of 816 pregnant women who were at
risk for GDM and had abnormal result of 50 g GCT (‡140 mg/dL)
before 20 weeks’ gestation were enrolled. All received 100 g oral glu-
cose tolerance test (OGTT) for the diagnosis of GDM. This 2-step
approach was repeated during 24–28 weeks’ gestation among those
with normal 100 g OGTTresults. Different cut-off values of 50 g GCT
for the diagnosis of GDM were evaluated.
Results: Mean age was 32.4 ± 5.1 years, and mean gestational age
when 50 g GCT was performed was10.1 ± 5.9 weeks. GDM was
diagnosed in 290 cases (35.5%) and mean gestational age at diagno-
sis was 19.1 ± 10.3 weeks. The risk of GDM increased with 50 g
GCT values. Of 19 and 13 women whose 50 g GCT values were
‡230 mg/dL and ‡240 mg/dL, 90.5% and 100% were diagnosed
with GDM respectively. Cut-off levels for GDM diagnosis among com-
mon risks were ‡230 mg/dL for family history of DM, ‡240 mg/dL
for age ‡30 years, and ‡220 mg/dL for obesity (BMI ‡27 kg/m2).
Results of 50 g GCT were not clearly related to GDM classification.
However, among GDM cases whose 50 g GCT <200 mg/dL, 99.1%
were in class A1.
Conclusion: 50 g GCT before 20 weeks’ gestation could be applied
and used for diagnosis of GDM using appropriate cut-off value.
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Profiles of cardiovascular risk in people with
type 2 diabetes: baseline data from a1chieve
study
LM CHUANG1, Z HUSSEIN2, MI HASAN3, P HOME4,
C SHEN5, ME KHAMSEH6
1National Taiwan University Hospital, Taipei, Taiwan;
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Newcastle Upon Tyne, UK; 5Novo Nordisk Pharmaceuticals,
Beijing, China; 6Tehran University of Medical Sciences, Tehran,
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People with type 2 diabetes (T2DM) are at high risk of developing
cardiovascular disease. Baseline data from the A1chieve observa-
tional study provide epidemiological data on cardiovascular risk pro-
files of people with T2DM (n > 30,000 for all measures) in 28
countries from Asia, Africa, Europe and Latin America. Regional
diversity was found in the prevalence of elevated BMI (>30.0
kg/m2), being 6.0% in China and 56.1% in Russia. Systolic blood
pressure (sBP) was 133 (SD 20) mmHg. Regionally mean total
serum cholesterol (TC) ranged from 4.7 (north Africa) to 6.0 mmol/
L (Russia). Mean sBP was also lowest in north Africa and highest in
Russia, 127 and 144 mmHg respectively, while TC was 5.2
(1.3) mmol/L, and LDL-C, HDL-C and triglycerides (TG) were 3.1
(1.1), 1.2 (0.4) and 2.1 (1.1) mmol/L, respectively. The overall per-
centage of patients failing to reach IDF-recommended target values
of LDL-C <2.5, HDL-C >1.0, TG <2.3 mmol/L and sBP
<130 mmHg were 70.1, 35.3, 30.8 and 43.9%, respectively. The
overall prevalence of microalbuminuria was 24.8%, with the highest
prevalence in people from the Middle East/Gulf region (37.9%).
Overall, proteinuria was reported in 6.4%, with marked regional var-
iation from 2.4% (east Asia) to 12.2% (north Africa). Of 40,456 peo-
ple not achieving target values, only 26.2% were being treated with
ACE inhibitors, 22.4% with aspirin and 20.1% with statins. Thus,
overall control of cardiovascular risk globally is poor, with many peo-
ple with T2DM not meeting guideline targets for risk protection.
Copyrightª 2012 John Wiley & Sons, Ltd.
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Diabetes mellitus following liver
transplantation: incidence, glucose monitoring
and treatment options in single centre
I DASKALOVA1, I TAKAROV2, E ODISSEEVA3,
T LUKANOVA3, R VELICHKOVA2, N VLADOV2
1Clinic of Endocrinology, Military Medical Academy, Sofia,
Bulgaria; 2HPB and Transplant Surgery, Military Medical
Academy, Sofia, Bulgaria; 3Anestesia and Intensive Care
Department, Military Medical Academy, Sofia, Bulgaria
New-onset diabetes mellitus (NODM) is a common metabolic com-
plication following liver transplantation, developed in approximately
15–20% of patients. It is associated with poor outcomes in regard to
a graft function and a patient survival. The aim of this study was to
evaluate the incidence and risk factors for diabetes after liver trans-
plantation in Bulgarian population. All 24 patients, who underwent
liver transplantation at MMA, Sofia from April 2007 to November
2010 were retrospectively reviewed and enrolled in the study. 20 of
them were male and 4 female with median age 43 years. HCV, HBV
and CMV status, recipient gender, age and body mass index, pre-
transplant arterial hypertension, serum glucose level, total insulin
dose used and immunosuppressive therapy were collected for each
patient. Tight glycemic control using continuous glucose monitoring
and insulin pump application was made perioperatively. We have
registered a new onset of DM in six of our patients. Everyone of the
examined group developed transient glucose intolerance within the
first two post transplant weeks. Patients, who developed PTDM are
males with alcoholic etiology of liver insufficiency, with overweight
or obesity. We did not find a significant correlation of PTDM with pre-
sence of HCV-, CMV-infection and pre-operative hypertension. No
increased percentage of graft rejection in this group was observed.
On the sixth month after transplantation five of the presented recipi-
ents required insulin treatment, but one who developed reversible
DM. The clinical impact of NODM has been underestimated in the
past. Prevention of NODM after liver transplantation requires a
planned and concerted effort, with thorough screening and risk
assessment of candidates and adherence to a regular schedule of gly-
cemic monitoring for all allograft recipients. The greatest attention
must be paid on the modifiable factors – the obesity in the pre-opera-
tive period and individualization of the immunosuppressive therapy.
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Single nucleotide polymorphisms of protein
tyrosine phosphatase 1B and risk of
hypertension
P GU1, H DU1, B LU1, J SHAO1, D ZOU2
1Department of Endocrinology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China; 2Department of
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University, Shanghai, China
Aim: To investigate whether Protein tyrosine phosphatase (PTP1B)
Single nucleotide polymorphisms (SNPs) are associated with hyper-
tension and hypertension related metabolic traits in Chinese subjects.
Methods: A total of 239 Chinese patients with hypertension and 141
non-hypertensive subjects were screened. The genotypes of PTP-1B
gene polymorphisms were determined by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) methods.
Results: The case-control study showed associations between the fre-
quencies of T allelic g54281 T>A and A allele of I5/37C>A and
hypertension. (P < 0.0001, P = 0.0371 respectively). In addition,
significant associations were observed between the IVS6 + G82A
polymorphism and waist circumference, total cholesterol and LDL
levels in hypertensive patients (P = 0.0005~0.0260). And g54281 T
allele was associated with higher plasma triglyceride (P = 0.0390)
and LDL- cholesterol concentration (P = 0.0141). While g58585
T>C was associated with BMI (P = 0.0308), waist circumference
(P = 0.0216) and HOMA-IR (P = 0.047). 0.047). Multivariate logis-
tic regression analysis showed that T allele carriers of g54281T>A
and A allele carriers of I5/37C>A had higher risks of hypertension
independent of age, gender, BMI, glucose levels and lipids profiles
(OR: 1.79, 95% CI: 1.09– 2.96, P = 0.02; OR: 1.66, 95% CI: 1.13–
2.44, P = 0.01, respectively).
Conclusions: PTP1B polymorphisms contribute to pathogenesis of
hypertension in Chinese subjects, and PTP1B SNPs may be involved
in the development of several features including dyslipidemia and
obesity in hypertension subjects.
O6
Cardiovascular safety of liraglutide: a pooled
analysis from phase II and III liraglutide clinical
development studies
YY HUANG1, SP MARSO2, AC MOSES3, MJ ZYCHMA3,
JB BUSE4
1Chang Gung Memorial Hospital, Taiwan; 2Saint Luke’s Mid
America Heart and Vascular Institute, Kansas City, MO; 3Novo
Nordisk, Bagsværd, Denmark; 4University of North Carolina at
Chapel Hill School of Medicine, Chapel Hill, NC
Introduction: Liraglutide is a human glucagon-like peptide-1 analog
approved for patients with type 2 diabetes. The US FDA currently
recommends analysis of major adverse cardiovascular events (MACE)
for new anti-diabetes drugs. The objective of this work was to per-
form a retrospective MACE analysis of the liraglutide development
studies.
Methods: Pooled analysis of patients in all completed intermediate/
long-term randomized trials plus open label extensions of liraglutide
drug development studies. Individuals with and without type 2 dia-
betes age 18–80, hemoglobin A1c 7–11% and BMI <45 kg/m2
exposed to liraglutide 0.045–3.0 mg/day, active control or placebo
were included. MACE (death, MI or stroke) were retrospectively
identified using medical dictionary for regulatory activities terms
with 3 search categories of varied sensitivity that were based on the
number of search terms associated with MI and stroke.
Results: In 15 phase 2 and 3 trials including 6,638 patients, there
were a total of 44, 43, and 32 serious MACE using broad, narrow
and custom search criteria, respectively. After expert evaluation, 39,
39 and 31 serious MACE identified using broad, narrow and custom
criteria, respectively, were adjudicated as MACE. The point estimate
of the incidence ratio for MACE associated with liraglutide was <1.0
for each MedDRA search.
Conclusions: In each MACE analysis, the point estimates for liraglu-
tide was <1.0 and upper 95% CI was <1.8, a specified upper bound
in FDA guidance for new anti-diabetes drugs. Liraglatide will be pro-
spectively evaluated in LEADERTM, a large scale, international, ran-
domized controlled cardiovascular outcomes trial.
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High serum IgA concentrations and risks of
impaired fasting glucose, hypertension, and
hypercholesterol among children
CC LIAO1, FC SUNG2, TC SU3, KL CHIEN3, YT LEE4
1Department of Anesthesiology, Taipei Medical University
Hospital; 2College of Public Health, China Medical University;
3Division of Cardiology, Departments of Internal Medicine,
National Taiwan University Hospital; 4Division of Cardiology,
Departments of Internal Medicine, China Medical University
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Objective: We evaluated the relationship between levels of immuno-
globulin A (IgA) and impaired fasting glucose, hypertension and
hypercholesterol among children.
Methods: From 1992 to 2000, a nationwide mass urine screening
was conducted to identify proteinuria, glucosuria, and/or hematuria
for all school graders in Taiwan Province. Students with urine screen-
ing positive twice received health check-up for anthropometric mea-
sures and selected blood tests including fasting glucose, total
cholesterol, albumin, blood urea nitrogen, and creatinine. We strati-
fied IgA concentration into deciles levels for measuring the associa-
tions with impaired fasting glucose and interaction with obesity.
Results: Among 92514 students with screening positive, the median
IgA level increased from 94 mg/dL in the lowest decile to 348 mg/dL
in the highest decile with a median of 190 mg/dL. Mean age, body
mass index, fasting glucose, blood pressure, and total cholesterol
increased as IgA increased, with impaired fasting glucose increased
from 11.0% in the lowest decile to 19.0% in the highest (P < 0.0001).
The corresponding prevalence of hypertension increased from 7.5% to
10.8%, respectively (P < 0.0001). School children with an IgA in the
highest decile had an adjusted odds ratios of 1.77 (95% confidence
interval [CI] = 1.62–1.93) for impaired fasting glucose; the odds ratio
increased to 2.93 (95%CI = 1.93–4.44) for obese children.
Conclusions: Our findings showed that children with higher IgA are
at higher risk of impaired fasting glucose, particularly for obese chil-
dren with high IgA.
O8
The ratio of leg-length over standing height as
a predictor of chilhood obesity: results from a
longitudinal cohort study
J LIU1, N AKSEER1, B FAUGHT1, J HAY1, J CAIRNEY2
1Brock University, St. Catharines, Canada; 2McMaster
University, Hamilton, Canada
Using data from a longitudinal cohort, we examined if leg-length to
height ratio (LLHR) measured at Grade Five was associated with obe-
sity risk at Grade Eight. A total of 1167 children (575 girls and 594
boys) from South Ontario, Canada who had no missing information
on body compositions in Grade Five and Grade Eight were included
in this analysis. Based on LLHR gender specific quartile cutoffs in
Grade Five, children were categorized into four groups (Q1–Q4).
Body mass index (BMI) was derived from weight (kg) and height
(cm) measured at Grade Eight; the gender and age specific BMI cut-
offs were used to categorize children as overweight/obese or normal
weight. Logistic regression models were used to examine the obesity
risk association with LLHR. After adjusting for age, total physical
activity score and waist circumference measured at Grade Five, in
comparing to those in Q1 of LLHR, the odds ratios (OR, 95%CI) of
overweight/obese for those in the Q2–Q4 were 0.60 (0.29, 1.21),
0.43 (0.21, 0.89), and 0.32 (0.15, 0.70) for boys, and 0.77 (0.36,
1.64), 0.60 (0.28, 1.29), and 0.27 (0.12, 0.62) for girls, respectively.
The P-values for trends were statistically significant in both genders
(P < 0.0001). When further adjusting early life experience variables
among a subsample (n = 566), the risk association pattern did not
change. The obesity risk association with LLHR remains even after
removing those who were considered as overweight/obese at Grade
Five. This suggests that LLHR can be considered as a potential screen-
ing tool to estimate obesity risk among children.
O9
Intra- islet protein- tyrosine phosphatase 1BFa
regulator of glucose- stimulated insulin
secretion?
B LU1, H WU2, P GU1, H DU1, J SHAO1, D ZAO2
1Department of Endocrinology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China; 2Department of
Endocrinology, Changhai Hospital, Second Military Medical
University, Shanghai, China
Aim: The aim of present study was to investigate the effects of intra-
islet inhibition of protein-tyrosine phosphatase 1B expression on glu-
cose-stimulated insulin secretion (GSIS).
Methods: Twenty ten-week-old SD rats were randomly assigned to a
regular diet (RD) or a high-fat diet (HFD) for 8 weeks. At the end of
study, fasting glucose, fasting insulin concentration and lipid profile
were measured and IPGTT was done after 12 h fast. Recombinant
adenoviruses containing siPTP1B (Ad-siPTP1B), or siControl (Ad-
siControl) sequences were constructed. Islets were isolated and trans-
fected and then assigned to Ad-siPTP1B group, Ad-siControl group,
and mock control group. RT-PCR and Western blot were used to eval-
uate the expression level of PTP1B, GLUT-2 and glucokinsase. Batch
incubation and islet perifusion were performed to evaluate kinetics
of insulin release.
Results: Intra-islet PTP1B expression in HFD group was higher than
that of RD group. GSIS was impaired in islets of HFD rats iP ƒ0.05).
Ad-siPTP1B treatment resulted in 73% decrease in PTP1B mRNA
levels and 61% decrease in PTP1B protein (p f0.05). Simulta-
neously, PTP1B inhibition resulted in 4.7} 0.8-fold increase of GSIS
from basal ip ƒ0.05). Perifusion showed notable improvement of first-
phase insulin secretion by Ad-siPTP1B treatment. And significant
decrease of both GLUT-2 and GCK were found in HFD group C while
up-regulation of both were achieved after PTP1B inhibiton.
Conclusions: Intra-islet PTP1B is an important physiological regulator
of glucose-induced insulin release.
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Association of maternal BMI with adverse
pregnancy outcomes- difference between South
Asian, South East Asian and Australian women
N MOIN, S HENDON, J BRADFORD, P HENRIKSSON,
M MCLEAN
University of Western Sydney and Blacktown Hospital, Sydney,
Australia
Maternal obesity is strongly associated with adverse pregnancy out-
come, but these data have mostly been derived from American or Eur-
opean populations. Different ethnic groups have differences in body
size and composition andwe should not assume similar degrees of risk
at the same level of BMI. There is a need for ethnic specific classifica-
tion of the association of BMI with obstetric risk. Our hospital network
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in Western Sydney serves an ethnically diverse population. 50% of
women attending the Obstetric Service are born outside Australia.
The most prevalent immigrant groups are from South Asia (Indian
sub-continent) or South East Asia. We used a computerized database
of women giving birth in Western Sydney to examine the association
between maternal BMI and pregnancy outcome. We compared
women born in South Asia (SA, n = 4783), South-East Asia (SEA,
n = 4026) or Australia (n = 18061) for composite measures of:(1)
adverse foetal outcomes (stillbirth, foetal anomaly, macrosomia,
admission to NICU); (2) adverse maternal outcomes (hypertension,
diabetes, need for assisted conception) and (3) Assisted delivery (Cae-
sarean or Instrumental). There was a graded increase of all three types
of adverse events with increasing maternal BMI, in all three popula-
tions. At any given BMI range>20women fromSA and SEA hadmore
adverse events than Australian-born women, and their obstetric risk
started to rise at a relatively lower BMI. Australian-born, but not SA or
SEA-born women hadmore adverse foetal events at a BMI.
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The outcome of beta cell function after early
insulin therapy in the recently diagnosed
type 2 diabetes (in Egyptian population) our
experience in El-Minia University Hospital
YM MOSA1, AM MOHAMED1, SH EL HINI1,
MS KAMEL1, AS SALAMA1, GM EL SAGHEER1,
AM OSMAN2
1Internal medicine department, Minia University, Egypt;
2Clinical Pathology Department, Minia University, Egypt
The purpose of this prospective cohort study was to evaluate whether
early insulin therapy is more advantageous in achieving long-term
optimal glycemic control with improved B cell function than oral
drugs in the recently diagnosed type 2 diabetes mellitus. Methods:
Sixty consecutive patients with recently diagnosed type 2 diabetes
mellitus were divided into 3 groups .The 1st group received 2 SC
injections of premixed insulin. The 2nd group received bed time NPH
and 3 injections of regular insulin before meals. The 3rd group
received metformin and/or sulphonylureas. The treatment continued
for 3 months till euglycemia was reached. Then, all medications were
stopped and the patients were followed up till the end of the year.
BMI, FBG, PPG, HbA1C, fasting level of insulin, proinsulin, C- pep-
tide, HOMA-IR, HOMA-B, serum cholesterol, triglycerides were esti-
mated. Results: Six patients from group I (30%), nine from group II
(45%), and only one from group III (5%) succeeded to maintain
euglycemia without further therapy for 9 months after stoppage of
treatment. The mean HbA1C level was 6.5% in group I, 6.1% in
group-2, and >7% in the group-3. Level of HbA1C in the succeeded
patients declined significantly in comparison to the failed patients.
Markers of B- cell function of the succeeded patients showed a statis-
tical significant increase regarding the C-peptide, insulin and HOMA-
B. Meanwhile, proinsulin level declined from 24.99 ± 0.99 before
treatment to 18.2 ± 5.1 after treatment (P = 0.0001) and proinsu-
lin/insulin ratio declined from 40.9 ± 14.5 before treatment to
18.19 ± 5.13 after treatment (P = 0.0001). The total serum choles-
terol declined from 206. 3 ± 36.7 before treatment to 176.3 ± 42.3
(P = 0.001) and triglycerides reduced significantly from
213.9 ± 79.1 before treatment to 160.3 ± 54.4 after treatment
(P = 0.001) of insulin treated groups Conclusions: Short-term insu-
lin therapy in a newly diagnosed type 2 diabetes insulin naive
patients can preserve B- cell function and insulin secretion, allowing
long-term glycemic control without medication and may improve gly-
cemic responses to supplemental oral treatment if needed.
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The protective effects of telmisartan on
intra-islet microvasculare in db/db mice
J SHAO, P GU, H DU, B LU
Department of Endocrinology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China
Objective: Several epidemiological studies suggested that treatment
with angiotensin II type 1 receptor blocker provided a risk reduction
of developing type 2 diabetes. Yet the mechanisms remain to be eluci-
dated. The aim of present study was to explore the effects of telmisar-
tan on intra-islet microvasculature in db/db mice.
Methods: Twenty-two db/db mice, 8 weeks of age, were randomized
to telmisartan 5 mg/kg and placebo via gavage for 6 weeks. Eleven
age-matched db/misty mice were studied concurrently treated with
placebo as non-diabetic controls. Body weight and random blood glu-
cose were measured every week. After 6 weeks’ treatment, Intraperi-
toneal glucose tolerance test, immunohistochemical staining of
platelet endothelial cell adhesion molecule 1 (PECAM1) were por-
formed. Islets were isolated and perifusion were performed to evalu-
ate kinetics of insulin release by using islet perfusion system. The
ultrastructure of intra-islet microvasculature was observed by elec-
tron microscopy.
Results: Six weeks’ telmisartan treatment improved glucose toler-
ance, insulin secretory function and insulin sensitivity. And islet beta-
cell mass was greatly rescued. Telmisartan treatment also improved
first-phase insulin response. And telmisartan treatment greatly
increased expression levels of PECAM1 in islets. Electron microscopy
showed more fenestration and caveolae in Telmisartan treatment
group. These results indicate that the beneficial effects of telmisartan
on glucose metabolism at least partly due to improved quality and
quantity of blood vessels in the islets.
Conclusions: Telmisartan treatment remarkably increased intra-islet
microvasculature volume, and improved early-phase insulin secre-
tion, thus protected beta-cell function.
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Corneal confocal microscopy: a novel
non-invasive method for early diagnosis of
diabetic periphereal neuropathy
C XUE1, J SHAO2, Z HUANG1
1Department of Ophthalmology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China; 2Department of
Endocrinology, Nanjing General Hospital of Nanjing Military
Command, Nanjing, China
Objective: Corneal confocal microscopy is a novel, rapid, non-inva-
sive in vivo clinical examination technique. We aimed to explore the
alterations in the early corneal innervation in relation to diabetic per-
ipheral neuropathy using laser confocal microscopy.
Methods: Forty-five type 2 diabetes were recruited and stratified into
diabetic peripheral neuropathy group (DPN), non-neuropathy dia-
betic group (NDPN) and 10 age-matched healthy control subjects
were studied. Diabetes duration, fasting plasma glucose, and HbA1C
were recorded. All underwent corneal confocal microscopic examina-
tion using the Heidelberg retina tomograph II with the Rostock cor-
neal module. The following parameters were measured and
analyzed: (1) Nerve fibre length (NFL); (2) Nerve branch density
(NBD); (3) Tortuosity coefficient (Tc).
Results: There were no significant differences of diabetes duration,
fasting plasma glucose, and HbA1C between DPN and NDPN group
at recruitment. Corneal epithelium nerve was straight and few bifur-
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cation in control group. Corneal NFL was significantly decreased in
DPN group when compared with control group and NDPN group
(P < 0.05). NBD was increase in NDPN group, but greatly decreased
in DPN group when compared with control group (P < 0.05). Tc was
significantly increased in in NDPN group, further aggravated in DPN
group (P < 0.05). Correlation analysis revealed that there were no
significant correlation of age, diabetes duration, fasting plasma glu-
cose, and HbA1C with NFL, NBD and Tc.
Conclusions: Corneal confocal microscopy is a rapid, non-invasive in
vivo clinical examination technique which accurately defines the
extent of corneal nerve damage and acts as a surrogate measure of
diabetic neuropathy.
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Association of Paraoxonase 1 gene
polymorphism with intima-media thickness
(IMT) of the carotid arteries in Japanese type 2
diabetic patients
I YAMAMOTO1, T HONDA1, K TAKADA1, M MAEDA2,
S NONEN2, T MOTOMURA3, K MAEDA3, Y FUJIO4,
J AZUMA2
1Azabu University, Kanagawa, Japan; 2Hyogo University of
Health Science, Hyogo, Japan; 3NTT West Osaka Hospital,
Osaka, Japan; 4Graduate School of Pharmaceutical Science,
Osaka University, Osaka, Japan
Aim: We investigated the association between paraoxonase 1
(PON1)-192 genotypes and IMT values of carotid arteries that corre-
late with the progression of systemic atherosclerosis in diabetic Japa-
nese patients.
Methods: One hundred and fifty-five Japanese type 2 diabetic
patients aged from 40 to 79 years without major cardiovascular
events and severe nephropathy were enrolled in this study. Geno-
types of the patients were determined by the PCR-RFLP method. IMT
of carotid arteries of the subjects was recorded by B-mode ultrasound
imaging.
Results: The genotypes QQ, QR and RR were found in 18(0.116),
70(0.452) and 67(0.432) patients respectively. IMT values of the RR
group were significantly greater (1.08 ± 0.41 mm, n = 67) than
those of the Q group, consisting of patients carrying one or two Q
alleles (0.95 ± 0.27 mm, n = 88, P = 0.023). There was no signifi-
cant difference in clinical characteristics between the two groups.
Conclusion: The results of this study indicate that PON1-192RR gen-
otype is associated with development of atherosclerosis.
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Diabetes complications and BMI in Asia, Africa,
Europe, and Latin America: A1chieve baseline
data
WY YANG1, G GONZALEZ-GALVEZ2, P HOME3,
IM HAJJAJI4, PN CHAKKARWAR5, P SOEWONDO6
1China-Japan Friendship Hospital, Beijing, China; 2Instituto
Jalisciense de Investigacion en Diabetes y Obesidad, Jalisco,
Mexico; 3ICM-Diabetes, The Medical School, Newcastle Upon
Tyne, UK; 4National Centre for Diabetes & Endocrinology;
5Novo Nordisk International Operations A/S, Zu¨rich,
Switzerland; 6Faculty of Medicine, University of Indonesia,
Jakarta, Indonesia
A1chieve is a multinational, open-label, observational study evaluat-
ing the safety and effectiveness of insulin analogues in people with
type 2 diabetes (n = 66,726) in routine clinical practice. The preva-
lence of complications at baseline, categorised by BMI according to
WHO Asia criteria (<20.0; 20.0 £ 23.0; 23.0 £ 25.0; 25.0 £ 27.5;
27.5 £ 30.0; ‡30.0 kg/m2), was estimated using a multivariate logis-
tic regression model, and presented as mean value of predicted prob-
ability (%). Overall, the probability of experiencing any complication
was lowest in the BMI group <20.0 kg/m2, 59.7% and greatest in
the BMI group ‡30.0 kg/m2, 75.2%. The trend of increasing prob-
ability of microvascular or macrovascular complications with increas-
ing BMI was seen across almost all regions. However, BMI appeared
to have little impact on predicting microvascular complications in
China (<20.0 vs. ‡30.0 kg/m2: 55.5 vs. 58.2%), while a decreased
probability with higher BMI was found in Latin America where BMI
<20.0 kg/m2 had a possibly higher probability of complications
(79.0 vs. 64.5% for BMI ‡30.0 kg/m2). Russia had the highest prob-
ability of reporting microvascular or macrovascular complications
compared with other regions, with 92.2 and 76.4% likelihood respec-
tively in people with BMI ‡30.0 kg/m2. The lowest probability of
microvascular complications was in south Asia with a 51.3% likeli-
hood with BMI <20.0 kg/m2, and of macrovascular complications in
Latin America with a 14.1% likelihood with BMI <20.0 kg/m2. In
general, increasing BMI was associated with higher probability of
having microvascular/ macrovascular complications, although with
regional variations.
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P1
Metabolic syndrome, the difference between
criterion in male subjects
FMS ADAM, JMF ADAM
Diabetes and Lipid Centre Wahidin Sudirohusodo Hospital,
Division of Endocrinology, Department of Internal Medicine,
Hasanuddin University,Makasar, Indonesia
Background: There is no universal criterion for the diagnosis of meta-
bolic syndrome. In 2001 the NCEP ATP III introduced the clinical
diagnosis of this syndrome. In 2005, the IDF introduced a new criter-
ion that modifies NCEPATP III. Another criterion was introduce by
AHA/NHLBI in 2010, basically the same as NCEP ATP III, except for
lower fasting blood sugar. Aim of this study is to compare the preva-
lence of metabolic syndrome among males using two different criter-
ion, IDF and AHA/NHLBI.
Subjects and methods: Subjects were from the East Indonesia Dia-
betes Epidemiology Group. In this study we focused only to male
subjects. We excluded those who were known as diabetes mellitus,
on treatment for hypertension, and dyslipidemia. After 12 h fasting,
blood were collected for fasting blood sugar, triglycerides, and HDL-
cholesterol. In this study we used the Asia-Pacific criterion for waist
circumference.
Results: During two years period 1439 males fulfill the criterion for
screening. Compared to IDF criterion, more subjects with metabolic
syndrome were diagnosed by AHA/NHLBI i,e 23.0% by IDF and
33.2% with AHA/NHLBI. The overlap between these two criterion
was 9.6%, whereas 13.4% have metabolic syndrome by IDF but
not AHA/NHLBI and 23.6% by the AHA/NHBI but not the IDF
criterion.
Conclusion: In this study, using the AHA/NHLBI detected more male
metabolic syndrome compared to IDF criterion.
P2
Impact of anti-diabetic medication on the
cardiovascular and renal outcome in patients
with diabetes mellitus
J AL WAKEEL1, D HAMMAD1, A MITWALLI1, A AL
HABI2, M AL GHONAIM1, A AL SUWAIDA1
1King Saud University, Riyadh, Saudi Arabia; 2Security Forces
Hospital University, Riyadh, Saudi Arabia
Background: Concerns have been raised that anti-diabetic agents
may themselves increase the risk of cardiovascular and renal events
in type 2 diabetic patients.
Objective: To investigate impact of anti-diabetic treatment by oral
hypoglycemic (OH) agents alone and combined treatment with insu-
lin and OH agents where Insulin was added after OH agents alone
failed to control hyperglycemia on cardiovascular and renal outcome
in type 2 diabetic patients.
Method: Retrospective study performed on 1952 diabetic patients in
Security Forces Hospital, facilitated by King Saud University, Riyadh,
Saudi Arabia from January 1989 to December 2004. Data included
patients demographics, co-morbidities, clinical and laboratory data,
cardiovascular, renal outcome and mortality.
Results: Total 1952 diabetic patients, 1073 on OH agents, 775 on
combine therapy of OH agents and insulin. Comparing baseline char-
acteristics of OH group vs. insulin and OH together. Age was
58.3 ± 14vs.59.6 ± 13.7 years, male sex 60.4%vs.43.4% (P = 00).
Duration of diabetes was 8.7 ± 6.7vs.12.9 ± 7.6 years (P = 0.00),
initial FBS was 9.6 ± 2.4 mmol/L vs. 9.7 ± 2.4 mmol/L. Initial
serum creatinine was 72 ± 35 vs. 74 ± 35 mmol/L. SBP was
132.3 ± 19 vs. 131.9 ± 19 mmHg while DBP was 78.2 ± 10 vs.
77.9 ± 10 mmHg. At last visit SBP was 128.4 ± 20 vs.
129 ± 21 mmHg P = 0.29, DBP was 78 ± 8 vs. 76 ± 9 mmHg,
doubling serum creatinine was 8.1% vs. 19.1% patients (P = 0.00),
uncontrolled hypertension was found in 18% vs. 21.2% patients
(P = 0.08).GFR <60 mL/min at last visit was 22.3% vs. 33.9%
patients. DN was 19.3% vs. 35.2% patients. Increased need of dialy-
sis was 2.2% vs. 6.3% patients (P = 0.00), greater incidence of MI
11.6% vs. 18.6% (P = 0.00), stroke 7.8% vs. 14.3% (P = 0.00), foot
infections 2.3% vs. 7.2% (P = 0.00) and mortality 7.5% vs. 9.5%
(P = 0.13) was observed in OH plus insulin treated group.
Conclusion: Addition of insulin late when OH agents failed to control
hyperglycemia has no benefit, rather risk of adverse renal and cardio-
vascular events and mortality increases in diabetic patients.
P3
Studying level of knowledge about of diabetes
and its relationship with demographic in nurses
to hygienic and medical centers in Sanandaj
city, IN 2007
N ALIRAMAEI, N SHARIFI, M SABERY, L MORADI
Kurdistan University of Medical Science, Sanandaj, Iran
Introduction: Diabetes is the third leading cause of death from dis-
ease. In 2000, according to the World Health Organization, at least
171 million people worldwide suffer from diabetes, or 2.8% of the
population. Diabetes mellitus occurs throughout the world, but is
more common in the more developed countries. The greatest
increase in prevalence is, however, expected to occur in Asia and
Africa, where most patients will probably be found by 2030. Nurses
who care for patients with diabetes must help them develop self –
care management skills.
Method: This was a descriptive and analytical study. The research
samples based on aim contain 180 persons. Data collection tools
include questionnaire containing 10 questions relating personal infor-
mation and 18 questions relating the rates of knowledge and using
chi – square.
Results: The findings showed that most test subjects were female
(77.2%) and (55.6%) between 31–40 years old. More than (78.3%)
married, and more than (71.7%) nurse for over 10 years (51.1%),
and also (37.8%) working in evening and night shift and suffering
from knowledge it (23/2%) well (56/4%) average and (40/4%)
weak, Also finding, showed that the rate of knowledge was good
(8.3%), medium (70%) and weak (21.7%).
Conclusion: Diabetes is a self – managed disease that requires many
strategies to keep it under control and a system of care to monitor
the prevention and provide early treatment of complications. Patients
are often more comfortable with nurses, and nurses spend more time
with patients and have the expertise to teach them to manage their
diabetes properly. The provision of care in nurse – directed clinics ma
contribute to keeping patients with diabetes healthy and free of com-
plications.
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P4
Body mass index associated with the number of
pregnancies in women referred to health
centers of Sanandaj
N ALIRAMAEI1, K ZOBEIRY2
1Kurdistan University of Medical Science, Sanandaj, Iran;
2Tehran University of Medical Science, Tehran, Iran
Introduction: Obesity is created for any reason, Should be treated as
a chronic disease. Based on results of research conducted, the most
appropriate body mass index is below 25. Pregnant women are con-
sidered among the most vulnerable groups of any population and are
required to receive health services appropriate and timely. Pregnant
women are suffering from a variety of problems during the ninth
month of pregnancy. Most discomfort is caused by physical and phy-
siological changes of pregnancy.
Methods: This is a descriptive – analytical method and Researcher
chose the research environment by cluster sampling method. Infor-
mation was gathered through a questionnaire, Regular interview and
measuring the weight and height of 300 women referred to health
centers in sanandaj.
Results: Results based on the body mass index showed 47 percent
overweight and 24 percent obesity and Severe obesity and only 7/
1% low-weight. There was also significant correlation between BMI
with age and parity. The majority of women age with 26/7% was
between 25–20 years and the majority were married (%90/3). Their
job, housewife (80%). Majority with 39/7% had primary education
up to sixth grade. 66/3% did not mention a specific disease. Results
also showed with 69/7% number of pregnancies was 1–2 times.
Discussion: Today, with the emphasis on population control and birth
limitation, gradually the role of women have been less important in
the family collection of children, increasing family size. According to
these results, 47% of women were overweight, and 24% were obese
and severely obese. Increasing weight and obesity greatly increases
the economic costs of health care. Due to poor awareness of pregnant
women seems necessary development and execution of educational
programs and prenatal care. Education and increasing women’s edu-
cation level has significant role in the health state of mothers and
children.
P5
Stroke and high blood pressure
N ALIRAMAEI1, K ZOBEIRY2
1Kurdistan University of Medical Science, Sanandaj, Iran;
2Tehran University of Medical Science, Tehran, Iran
Introduction: High blood pressure is the most significant known risk
factor for stroke. Hypertension is often called ‘the silent killer’
because most people don’t even realize they have it. High blood pres-
sure is when your blood pressure is consistently over 140/90. A per-
son with untreated hypertension is four times more likely to have a
stroke than someone whose blood pressure falls within the healthy
range.
Methods: This study is done by a cross-sectional descriptive method.
All the 100 patients with CVA who were present in the place of
research were selected on an easy and objective- based method. The
information was completed through questionnaire and interview,
and then scored and statistically analyzed.
Results: Results showed that the samples (53%) females aged 70–
51 years with majority of 48% and 38% housewives, the majority of
illiterate, and 55% with previous history of stroke did not attack.
Total days of hospitalization varied between 5 and 9 days with 43%
of rural residence, and admission with 42% suffering from paralysis
of four limbs that 79% had no obvious impairment of speech and
they mostly had high blood pressure for 4–7 years. Also between
high blood pressure and stroke with P < 0.005 a significant relation-
ship was shown.
Discussion: A stroke is a medical emergency and can cause perma-
nent neurological damage, complications, and death. It is the leading
cause of adult disability in the United States and Europe and it is the
number two cause of death worldwide. Risk factors for stroke include
advanced age, hypertension, previous stroke or transient ischemic
attack (TIA), diabetes, high cholesterol, cigarette smoking and arter-
ial fibrillation. High blood pressure is the most important modifiable
risk factor of stroke Artillery hypertension is the most important
hygienic problem in developed countries, which if not cured will lead
to fatal complications.
P6
Evaluating the relationships of circulatory
measures with estimation of cardiovascular
endurance using a non-exercise model in young
asymptomatic males and females
MA ALOMARI1, DM SHQAIR2, K ALAWNEH3,
OF KHABOUR4, ME NAZZAL5, EF KEEWAN6
1Division of Physical Therapy, Department of Allied Medical
Sciences, Jordan University of Science and Technology, Irbid,
Jordan; 2Department of Nutrition, Jordan University of Science
and Technology, Irbid, Jordan; 3Division of Rheumatology,
Department of Medicine, King Abdulla Hospital; 4Department
of Medical Laboratory Sciences, Jordan University of Science
and Technology, Irbid, Jordan; 5Department of Rehabilitation
Medicine, Faculty of Medicine, Jordan University of Science and
Technology; 6Department of Physiology, Faculty of Medicine,
Jordan University of Science and Technology, Irbid, Jordan
Introduction: The diagnostic value of graded exercise testing for car-
diovascular (CV) diseases (CVD) screening in asymptomatic indivi-
duals was recognized sometime ago. However, the risk, time
constrains, inconvenience, and cost associated with exercise testing
prevent from using the maximal oxygen consumption (VO2max)
measure frequently. A recent model is proposed to estimate VO2max
without exercise. This study, examined the relationships of the non-
exercise model (NM) with circulatory measures of blood pressure
(BP) including diastolic (DBP), and mean (MAP), as well as forearm
resting blood flow (RBf), and vascular resistance (RVr), and post-
occlusion blood flow (OcBf) in 188 young (18–40 years) asympto-
matic males (M) and females (F).
Methods: The equation used to estimate VO2max was: [Gender(fe-
male = 0; male = 1)*2.77] - [Age*0.10] - [BMI*0.17] - [resting
heart rate(HR)*0.03] + [PAlevel*1] + 18.07. Automated ausculta-
tory was used to measure BP and HR whereas strain-gauge plethys-
mography was used to measure RBf, RVr, and OcBf after 20 min of
supine resting.
Results: Estimated VO2max correlated with DBP (F: r = -0.3;
P = 0.005,M: r = -0.2; P = 0.03), andMAP (F: r = -0.2; P = 0.005,
M: r = -0.2; P = 0.04) as well as RBf (r = 0.2; P = 0.02), OcBf
(r = 0.3; P = 0.02) and RVr (r = -0.2; P = 0.03). Additionally, the
ANOVA revealed differences in OcBf (P = 0.000), and RVr (P = 0.05)
between the poor, average, and highNMVO2max groups.
Discussion: The results show relationships of NMVO2max with circu-
latory measures confirming previous findings using direct VO2max.
The relationships further demonstrate the importance of CV endur-
ance for maintaining circulatory health. Since BP measures are estab-
lished risk factors and components of the metabolic syndrome, these
relationships further add to the scientific and clinical values of NM.
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P7
Obesity relationship with non-exercise
estimation of cardiovascular endurance in
young asymptomatic males and females
MA ALOMARI1, DM SHQAIR2, K ALAWNEH3,
OF KHABOUR4, ME NAZZAL5, EF KEEWAN6
1Division of Physical Therapy, Department of Allied Medical
Sciences, Jordan University of Science and Technology, Irbid,
Jordan; 2Department of Nutrition, Jordan University of Science
and Technology, Irbid, Jordan; 3Division of Rheumatology,
Department of Medicine, King Abdulla Hospital; 4Department
of Medical Laboratory Sciences, Jordan University of Science
and Technology, Irbid, Jordan; 5Department of Rehabilitation
Medicine, Faculty of Medicine, Jordan University of Science and
Technology, Irbid, Jordan; 6Department of Physiology, Faculty of
Medicine, Jordan University of Science and Technology, Irbid,
Jordan
Obesity is a major risk factor for cardiovascular (CV) diseases (CVD),
a component of the metabolic syndrome, and a leading cause of
death in the world. The direct measure of CV endurance (CVE) has
been recommended to be used in the screening for CVD in asympto-
matic individuals. The non-exercise model (NM) to estimate CVE
(NMCVE) has been proposed as an alternative for the direct measure.
However no studies have examined the relationship of obesity with
NMCVE. Therefore, the study examined the relationships of obesity
measures with NMCVE. Weight (wgt), percent body fat(%BF),
waist(WC), and hip(HC) circumferences, WC and HC ratio(WHR),
and body mass index(BMI) were used as measures of obesity. The
equation used to estimate CVE was: VO2max = [Gender (female = 0;
male = 1)*2.77] - [Age*0.10] - [BMI*0.17] - [resting HR*0.03] +
[PA level*1] + 18.07. Subsequently, the relationships between obe-
sity measures and NMCVE were examined in 188 asymptomatic
males and females. The participants’ NMCVE correlated significantly
(P > 0.05) with wgt, %BF, muscle mass, body water content, WC,
HC, WHR in the males (r = 0.2–0.7) and females (r = 0.2–0.7).
Additionally, the ANOVA (P > 0.05) revealed significant difference in
wgt, BMI, %BF, muscle mass, body water content, WC, and HC
between the NMCVE low, moderate, and high groups. This is the first
study to report relationships between NMCVE and obesity measures.
These results confirm the relationship between obesity and CVE
using the direct measures, suggesting the importance of maintaining
aerobic endurance for weight control. Additionally, since obesity
measures are established risk factors and components of metabolic
syndrome these relationships further enhance the value of the non-
exercise model thus can be used in scientific and clinical settings.
P8
Cardiovascular disease (CVD) risk factor and
high costs of CVD in Mexican Americans with
diabetes mellitus
J APONTE1
1Hunter College, New York, USA
Context: One of the primary macrovascular complications in people
with diabetes mellitus (DM) is cardiovascular disease (CVD). CVD is
the most costly complication of DM. Costs of DM and macrovascular
complications are 2.7 times higher than costs of DM without compli-
cations.
Objectives: Low-density-lipoproteon (LDL) is an independent risk fac-
tor of CVD and the primary macrovascular complication of DM. The
National Health and Nutrition Examination Survey (NHANES)
1999–2000 and NHANES 2001–2002 were utilized to examine and
compare LDL levels in Mexican Americans (MA) with DM.
Methods: The NHANES 1999–2000 and NHANES 2001–2002 data
sets were utilized in this study. Descriptive statistics and Chi-
squares were computed. The sample comprised participants who
self identified as MA, being told by a doctor as having DM, and
between 20–74 years of age. LDL was the variable measured in
this study.
Results: The findings showed that even though changes in both, nor-
mal LDL levels (<100 mg/dL) and elevated LDL levels (>100 mg/
dL) were not significant (P = 0.8129–0.9132), there was a slight
decrease in people with elevated LDL levels (>100 mg/dL) from the
NHANES 1999–2000 (74%) to the NHANES 2001–2002 (66%)
(P = 0.8129). Although there was an 8% decrease in elevated LDL
levels (>100 mg/dL), over 50% of those with an elevated LDL level
were at high risk for CVD.
Conclusion/Implications: This study shows that MA with DM are at
high risk for CVD. Therefore, future research should include studies
identifying specific cultural factors relative to the management of
DM and risk factors for CVD.
P9
Development of food insulin index (FII)
J BAO1, F ATKINSON1, P PETOCZ2, W WILLETT3,
J BRAND-MILLER1
1Boden Institute of Obesity, Nutrition & Exercise, the University
of Sydney, Sydney, Australia; 2Department of Statistics,
Macquarie University, Sydney, Australia; 3Harvard School of
Public Health, Harvard University, USA
Objectives: A greater understanding of dietary insulin demand is
important in the management of diabetes. Carbohydrate counting
and glycemic index leave out a majority of non-carbohydrate foods
in terms of predicting insulin responses. We developed a food-insu-
lin-index (FII) for ranking iso-energetic foods (1000 kJ) according to
insulin demand and systematically gathered available data.
Methods: Published and unpublished data were collected between
1997 and 2008. To date, there are 120 data entries, for nine cate-
gories of foods, all tested in 10 healthy subjects. Correlations
between FII values and nutrients were examined.
Results: Significant differences in FII values were noted within and
between food categories. Within food groups, insulin demand varied
over a two-fold range among the vegetable group and over a 20-fold
range among the fruit group. Carbohydrate, protein and fat, but not
fibre, were related to insulin responses (r = 0.68, -0.26 and -0.51,
P < 0.01).
Conclusion: The FII database may be helpful in exploring relation-
ships between insulin demand and diabetes and related complica-
tions.
P10
Effect of two diets of varying food insulin index
(FII) on day-long (8-hour) profile of insulin
secretion
J BAO1, F ATKINSON1, P PETOCZ2, J BRAND-MILLER1
1Boden Institute of Obesity, Nutrition & Exercise, the University
of Sydney, Sydney, Australia; 2Department of Statistics,
Macquarie University, Sydney, Australia
Objective: Prolonged or high degrees of postprandial insulinemia are
linked to epidemics of diabetes, obesity and other metabolic abnorm-
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alities. This study aimed to investigate the insulinemic effects of two
diets with similar marcronutrients, fibre and GIs but disparate food
insulin index (FII) over the course of a whole day.
Methods: 10 lean, healthy subjects consumed a high and a low FII
diet in a randomised, crossover design, consisting of three meals in
two separate days. Two diets were matched for macronutrients, fiber
and GIs but had different insulin demand assessed by FII (65 vs. 30).
Capillary blood was sampled every 30 min from 08:30 until 16:30
and assayed for glucose and insulin.
Results: The insulin mean incremental areas under the curve (AUC)
during the day the low FII diet was ingested was more than 50%
lower than on the day of high FII diet (low FII diet: 32 ± 4 nmol/
L*min vs. high FII diet: 68 ± 11 nmol/L*min, P = 0.003) whereas
there was no significant difference in glucose response (AUC) (low
FII diet: 330 ± 88 vs. high FII diet: 387 ± 70 mmol/L*min,
P = 0.73). Mean fasting insulin and glucose concentrations didn’t
differ significantly on both days (P = 0.069 and 0.066, respectively).
Conclusions: This study provides the first clinical evidence of the phy-
siological validity of the concept of food insulin index as a measure of
day-long glucose and insulin profiles in a whole-diet context in lean,
young healthy subjects.
P11
Normal insulin demand for dose adjustment:
the Nidda study
J BAO1, H GILBERTSON3, R GRAY2, D MUNNS2,
G HOWARD2, S COLAGIURI1, J BRAND-MILLER1
1Boden Institute of Obesity, Nutrition & Exercise, the University
of Sydney, Sydney, Australia; 2Sydney Insulin Pump Clinic,
Sydney, Australia; 3Centre for Adolescent Health, Royal
Children’s Hospital, Melbourne, Australia
Objective: Carbohydrate counting assumes only the quantity of car-
bohydrate influences insulin dose required in type 1 diabetes. A food
insulin index (FII) has been developed and validated for predicting
normal insulin demand generated by mixed meals in healthy adults.
We sought to compare a novel algorithm based on the FII for estimat-
ing mealtime insulin dose with carbohydrate counting in adults with
type 1 diabetes.
Research Design and Methods: Twenty eight participants consumed
two different breakfast meals of equal energy, glycemic index, fibre
and predicted insulin demand (FII = ~60 for both meals) but ~2-
fold difference in carbohydrate content, in random order on 3 conse-
cutive mornings. Meal A was consumed using carbohydrate counting
only. Meal B was consumed on two occasions, once using carbohy-
drate counting as the basis for the insulin dose (ie half dose as Meal
A) and once using the novel algorithm (same dose as Meal A). Real-
time continuous glucose monitor was used to assess postprandial gly-
cemia.
Results: Compared with carbohydrate counting, the novel algorithm
significantly decreased glucose incremental area under the curve
over 3 h (-52%, P < 0.01), peak glucose excursion (-41%,
P = 0.001) and improved the percentage of time within the normal
BGL range (4–10 mmol/L) (+31%, P < 0.001). There was no signif-
icant difference in the occurrence of hypoglycemia.
Conclusions: The findings support the use of a novel algorithm based
on insulin demand in healthy subjects to optimize glycemic control
without increasing the risk of hypoglycemia in type 1 diabetes
patients using insulin pump therapy.
P12
A prevalence study of depression and anxiety
among adults with type 2 diabetes mellitus
SN BASAK1,3, S RAI2,3
1MGMMedical College, Navi Mumbai, India; 2Department of
Medicine, MGM Medical College, Navi Mumbai, India; 3Indian
Council of Medical Research, Ansarinagar, New Delhi, India
Background: The WHO has projected that 300 million people will
suffer from diabetes by 2025. ‘India’ is the number one contributor to
this. A history of major depression was found in 33% of the patients;
despite that, it is frequently unrecognized and untreated. Depression
is associated with hyperglycemia and may affect the glycemic control
and increase the risk of diabetic complications. This research was
done to get an accurate idea of severity in depression and anxiety in
adults with DM which will help us cope with the consequences.
Methods: A sample size of 100 adults with Type 2 diabetes was con-
sidered after a certain inclusion and exclusion criteria. An OPD based
cross-sectional study was done during 2010. Data regarding demo-
graphics, anthropometrics, biochemistry, micro and macrovascular
complications of diabetes were considered. Following which they
were given to fill the Beck Depression Inventory -2 and Clinical Anxi-
ety Scale which was used to assess depression and anxiety respec-
tively.
Results: More prevalent in men in a mean age group of ‡56 years
(OR = 1.09, 95% CI = 0.6–1.9), with obesity (OR = 1.6, 95% CI =
0.9–2.8), mean duration of 5–10 years.69% of the patients had a
family history of diabetes, 15% were hypertensive. Based on BDI- II,
38%, 44% were severely, moderately depressed respectively. Also,
65% of the diabetic population is suffering from moderate anxiety,
both of which are associated with agitation, irritability, tiredness and
changes in appetite.
Conclusion: Depression and Anxiety in adults with type 2 diabetes is
largely prevalent esp, in males and in older age group with a long
span of diabetes. Diabetes and depression can thus pretty much lead
to development of the other. Hence, it is very essential to monitor
our lifestyles now than regret later.
P13
Obesity and gastroparesis in type 2 diabetic
patients with neuropathy
M BOAZ1,2, J KISLOV3, J WAINSTEIN3
1Epidemiology and Research Unit, E. Wolfson Medical Center,
Holon, Israel; 2Nutrition Department, School of Health
Sciences, Ariel University Center, Ariel, Israel; 3Diabetes Unit, E.
Wolfson Medical Center, Holon, Israel
Background: Associated with neuropathy, symptoms of gastroparesis
are common in patients with type 2 diabetes mellitus (T2DM) and
include nausea, vomiting, bloating, and early satiety associated with
delayed gastric emptying. Gastric motor abnormalities have been
reported in obese patients, and obesity is associated with T2DM. An
association between obesity and gastroparesis symptoms in diabetic
patients with neuropathy has not been investigated.
Methods: In a cross-sectional survey of gastroparesis prevalence in
380 T2DM patients, 161 were identified as having neuropathy. Gas-
troparesis symptom prevalence was compared by obesity (BMI ‡ 30
kg/m2). A general linear model of number of symptoms was devel-
oped.
Results: Subjects were 66.6 ± 10 years of age, 51% female, diabetes
duration 15.6 ± 8.2 years, fasting blood glucose 159 ± 69 mg/dL,
HbA1c 8 ± 1.6% and 56.5% obese. Obese subjects reported signifi-
cantly more early satiety (61.5% vs. 35.2%, P = 0.001); fullness
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(63.7% vs. 40.8%, P = 0.004); bloating 70.3% vs. 49.3%,
P = 0.006) and abdominal distention (71.4 vs. 50.7%, P = 0.007)
than non-obese subjects. Obese subjects were more likely to have any
gastroparesis symptom (RR 2.4, 95% CI 1.01-5.9, P = 0.04); more-
over, obese subjects reported more gastroparesis symptoms: 4 (0–10)
vs. 3 (0–8), P = 0.005. In the model of number of gastroparesis
symptoms, obesity persisted as a significant, independent predictor
even after controlling for age, sex and HbA1c (P = 0.03).
Conclusions: Obesity emerged as a significant, independent predictor
of gastroparesis symptoms in patients with T2DM and neuropathy.
This finding suggests that mechanisms in addition to neuropathy -
perhaps hormones such as ghrelin - play a role in the pathogenesis of
gastroparesis in this patient population.
P14
Jewish new year associated with decreased
point of care glucose in hospitalized patient
population
M BOAZ1,2, Z LANDAU3, Z MATAS4, T CHAIMY4,
J WAINSTEIN3
1Epidemiology and Research Unit, E. Wolfson Medical Center,
Holon, Israel; 2Nutrition Department, School of Health
Sciences, Ariel University Center, Ariel, Israel; 3Diabetes Unit,
E. Wolfson Medical Center, Holon, Israel; 4Biochemistry
Laboratory, E. Wolfson Medical Center, Holon, Israel
Background: In individuals with diabetes, glycemic control has been
shown to be disrupted during the winter holiday period.
Methods: Blood glucose values from individuals hospitalized in inter-
nal medicine units were collected and analyzed during the period
surrounding Rosh Hashanah, the Jewish New Year, 2010. Values
obtained between 4–7 September 2010, were categorized as pre-holi-
day values; values from 8–11 September 2010 were classed as holi-
day values; and values from 12–15 September 2010 were labeled
post-holiday values. All values were collected at point of care (POC)
using an automated, institutional glucometer located in each depart-
ment, the data from which is downloaded to a central hospital-wide
database.
Results: A total of 3403 POC glucose values were recorded during the
observation period. POC glucose values were significantly lower dur-
ing the Rosh Hashanah holiday than the pre- or post-holiday periods:
176.8 ± 81.3 vs. 181.4 ± 78.8 or 184.9 ± 83.02, P = 0.03. During
the Rosh Hashanah holiday, mean patient age was significantly older
than the pre- or post-holiday period: 77.4 ± 10.9 vs. 74.9 ± 12.0 or
75.3 ± 11.8, P < 0.0001; however, age predicted less than 1% of
the variability in POC glucose: r = 0.02, P = 0.23. In a linear regres-
sion model, holiday period remained a significant independent pre-
dictor of POC glucose even after controlling for age and sex.
Conclusions: POC glucose was significantly lower during the Rosh
Hashanah period relative to pre- and post-holiday values. This may
reflect a shift in the composition of the hospitalized patient popula-
tion during the holidays towards older individuals with more
restricted dietary intake.
P15
Insulinemia and blood pressure in obesity
M BOZ, E ULGEN, C MUDERRISOGLU, F AKTAS,
E ALTUNOGLU, F ERDENEN, M ERGUNEY
Istanbul Training and Research Hospital, Clinics of Internal
Medicine
Introduction and objectives: The relation between body weight and
arterial blood pressure is reported since many years in obese popula-
tion. However, a causal link between insulin resistance and Type 2
diabetes or hypertriglyceridemia and metabolic syndrome is not well
demonstrated. The aim of this study is to examine the relationships
between insulin levels and arterial blood pressures, glycemia, trigly-
ceridemia and some others parameters linked to metabolic syndrome
in obese population.
Methods: 195 obese patients were pooled out followed in our out-
patient clinics. We accepted only between 40–60 years old and non-
diabetic patients. Some characteristics of this population: age (years).
48.6 ± 5.2, Waist circumference (cm):112.2 ± 15.1, WHR (Waist
Hip Ratio): 0.87 ± 0.7, SBP (Systolic Blood Pressure:
mmHg):132.3 ± 18.7, DBP (Diastolic Blood Pressure mmHg):
80.7 ± 10.FBG (Fasting Blood Glucose mg/dl):103.5 ± 27.7, trigly-
ceridemia (mg/dL):156.8 ± 78.5 and BMI (Body Mass Index:
Weight (kg)/Height (m2): 38.9 ± 7.6.
Results: When we divided the study group into two groups according
to insulin levels (10 mU/L) < or >): increased BMI, waist circumfer-
ence but not WHR and C-peptide, FBG, triglyceridemia significantly
(P < 0.0001) are in the high insulin level group. Elevated SBP
(P < 0.03) but not DBP, decreased HDL (P < 0.07) and HbA1C
(P < 0.01) also in the same group. Inversely when we divided into
two groups according to SBP levels (120 mg < or >): increased BMI,
DBP (P < 0.0001), waist circumference (P < 0.001) but not WHR,
and increased FBG (P < 0.01), triglyceridemia (P < 0.01), insuline-
mia (P < 0.007) and C-peptide (P < 0.003) are in the elevated SBP
group.
Conclusion: Hyperinsulinemia and elevated SBP are associated vari-
ables in obese patients. These parameters are the main components
of metabolic syndrome.
P16
Metabolic syndrome and hypothyroidism -
additional risk factors in cardiovascular
diseases
EG CIRCO, MN BECIU, RE CIRCO
Ovidius University, Constanta, Romania
Introduction: Hypothyroidism correlate with metabolic syndrome is
one of the major causes of risk in the development of degenerative
cardiovascular pathology.
Methods: Patients were evaluate the characteristics of metabolic syn-
drome and dosage of the serum metabolic constant; assessment of
the thyroid (serum hormone dosage level, thyroid antibodies, thyroid
and cardiac ultrasonography). The data obtained were assessed in
two differentiated study groups: group 1 - patients with cardio-vascu-
lar disease, metabolic syndrome and thyroid disease; group 2 -
patients with cardio-vascular diseases and thyroid disease without
metabolic syndrome.
Results: The incidence of metabolic syndrome in the study group
was 45%. A percentage of 86% of patients with metabolic syndrome
and endocrine diseases were associated with primary hypothyroid-
ism. Females had a net prevail in group 1 (85%) and in group 2
(90%). The incidence of cardiovascular complications was maximum
in group age 51–60 (54%). Cardiovascular complications were signif-
icantly as increased incidence (P < 0.001) among cardiac patients
associating metabolic syndrome and hypothyroidism. Index calcula-
tion non-HDL - cholesterol revealed a higher risk among patients in
group 2 (64%) associated with hypothyroidism, compared with those
of batch 1 (47%). Hyperuricaemia was encountered more frequently
among patients in group 2 (58%) compared to those in group 1
(42%). 86% of cases had primary hypothyroidism, sex ratio
F:M = 8:1. Cardiovascular complications were significantly higher
among patients with metabolic syndrome and hypothyroidism
(P < 0.001); atherogenic index was 4.8 – group 1 and 5.6 – group 2.
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Conclusions: Among patients with cardio-vascular diseases asso-
ciated metabolic syndrome is frequent. Hypothyroidism represents an
additional risk factor. It is necessary to determine serum thyroid hor-
mones levels for the patients with coronary heart disease.
P17
Metabolic syndrome – possible marker for
adrenal incidentaloma functionality
EG CIRCO, MN BECIU, RE CIRCO
Ovidius University, Constanta, Romania
Introduction: The adrenal incidentaloma is defined as a mass lesion
found unexpectedly in an adrenal gland by an imaging procedure
performed for another reason than suspected adrenal pathology.
Objective: To estimate the incidence of the adrenal mass and to
define the algorithm for managing patients with incidental adrenal
mass and metabolic syndrome
Methods: Were studied 41 patients (7 men and 34 women) with
typical computed tomography features of adrenal mass. The structure
of the adrenal incidentaloma group (n = 34) was: batch A-nonsecre-
tory tumors (n = 21) (61.8%-TN) and batch B-secretor tumors
(n = 13) (38.2%-TS) whereby 4 patients with one-sided pheochro-
mocytoma, 5 with Cushing syndrome, 2 with subclinical Cushing
syndrome and 2 with adrenal hypertrophy.
Results : Overweight or obesity were found in 33,3% by batch A and
30,8% by batch B; hypertension in 61,9% by batch A and 69,2% by
batch B; diabetes mellitus in 19% by batch A and 30,8% by batch B;
dislipidemia in 42,9% by batch A and 30,8% by batch B; osteoporosis
in14,3% by batch A and 23,1% by batch B.
Conclusions: The tumor assess, the imagistic features and the quality
of secretory/ nonsecretory tumor is essential. Some features of the
metabolic syndrome described to the patients with adrenal incidenta-
lomas are enlarged the medically problem and sometime may be con-
sidered the evidence for functional involvement of incidentaloma.
P18
The incidence of metabolic syndrome in a group
of patients with impaired glucose tolerance
EG CIRCO, M SECELEANU, MN BECIU
Ovidius University, Constanta, Romania
Introduction: Altered carbohydrate metabolism is a component of
metabolic syndrome symptoms.
Aim of the study: Determination of incidence and the cardiovascular
risk of metabolic syndrome in patients with impaired glucose toler-
ance.
Material and method: Descriptive study, epidemiological and trans-
verse including 362 adult patients with impaired glucose tolerance.
Diagnostic criteria of metabolic syndrome were defined by the ‘‘Inter-
national Diabetes Federation (IDF),’’ The 3rd Report of the National
Cholesterol Education Program (NCEP-ATP III) and the World Health
Organization (WHO).
Results: The incidence of metabolic syndrome was: 80.2% (IDF) and
72.6% (NCEP-ATP III) and 68.5% (WHO); among smokers was sig-
nificantly higher (P < 0.005) 93% (IDF), 84% (NCEP-ATP III) and
81% (WHO) than non-smokers: 64% (IDF), 61% (NCEP -ATP III)
and 57.4% (WHO). Percentage metabolic syndrome was more com-
mon in sedentary patients: 91.5% (IDF), 81.2% (NCEP-ATP III) and
80% (WHO) vs. those with constant physical activity 73.2% (IDF),
69.8% (NCEP-ATP III) and 71% (WHO) (P < 0.001); was more
common (P < 0.001) in males compared with females: 61% / 39%
(IDF) 63% 37% (NCEP-ATP III) and 58% 42% (WHO); low signifi-
cant (P < 0.05) for alcohol consumption.
Coronary heart disease and stroke were more frequent
(P < 0.001) in patients with metabolic syndrome than those without
symptomatic criteria of syndrome: 27%/2% (IDF), 38%/5% (NCEP-
ATP III) and 25%/7% (WHO); moderate significance (P < 0.05%)
in men compared to women: 18% / 12% (IDF), 21% / 15% (NCEP-
ATP III) and 17% / 11% (WHO).
Conclusions: Association of metabolic syndrome / impaired glucose
tolerance is common. Prevention of cardiovascular complications for
these patients involves early diagnosis of metabolic syndrome.
P19
Effects of diabetic ketoacidosis on vitamin D
levels
R DANCIULESCU MIULESCU1, J CRISTESCU1,
S DANOIU2
1Institute Prof. N. Paulescu Bucharest, Romania; 2UMF
Craiova, Romania
Background and Aims: Clinical and experimental evidence suggests
that chronic metabolic acidosis alters vitamin D metabolism. The aim
of the present study was to investigate the levels of vitamin D in
patients with acute metabolic acidosis.
Materials and Methods: 17 patients with type 1 diabetes and moder-
ate or severe metabolic acidosis (according American Diabetes Asso-
ciation statement, moderate acidosis: pH between 7.00–7.25 and
bicarbonate between 10–15 mmol/L, severe acidosis: pH below 7.00,
bicarbonate below 10 mmol/L) were recruited for this study. Plasma
25-hydroxyvitamine D was assessed with a radioimmunoassay kit.
These results were compared those of the control group consisting
of 12 patients with type 1 diabetes, but without metabolic acidosis.
Results: The subjects of the study group: 8 women (47.05%) and 9
men (52.94%) were between 26 and 38 years old, with mean age
30.20 ± 3.22 years. 13 patients (76.47%) present moderate meta-
bolic acidosis and 4 patients (23.52%) present severe ketoacidosis.
The prevalence of vitamin D insufficiency in patients with moderate
or severe metabolic acidosis was 41.17% (7 patients-3 women and 4
men). 2 patients with severe metabolic acidosis (11.76%- 2 men)
present vitamin D deficiency. The prevalence of vitamin D insuffi-
ciency in patients with type 1 diabetes but without metabolic acidosis
is 25% (3 patients -1 woman and 2 men).
Conclusion: There is considerable evidence supporting the role of
vitamin D deficiency in the pathogenesis of type 1 diabetes mellitus.
Acute metabolic acidosis may alter vitamin D metabolism.
P20
Improvement of early-phase insulin response
and glucose tolerance by rhein in db/db mice
H DU1, J SHAO1, P GU1, B LU1, J WANG1, Z LIU2
1Department of Endocrinology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China; 2Research
Institute of Nephrology, Nanjing Jinling Hospital, Nanjing,
China
Objective: Rhein (4,5-dihydroxyanthraquinone-2-carbxylic acid) is
one of the most important active components of rhubarb (Rheum
officinale), a traditional Chinese herb widely used to cure diseases
associated with over-nutriention by Chinese emperors in ancient
time. Recently, it has been found to be valuable in chronic inflamma-
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tory diseases. In the present study, we aimed to investigate whether
rhein have effects on insulin secretory function and glucose tolerance
in diabetic db/db mice.
Methods: Thirty 4-week-old db/db mice were randomized to treat-
ment with rhein (120 mg/Kg) and placebo (1% natrium cellulose
solution) by gavage for 8 weeks respectively. Age-matched non-dia-
betic littermates db/m mice treated with placebo were studied as
non-diabetic control. Body weight and blood glucose level were
measured every week. After 8 weeks’ treatment, IPGTT was done
and immunohistochemical staining of insulin was performed to esti-
mate beta-cell mass. AUC (area under curve) of insulin levels in
IPGTTwas calculated to evaluate insulin secretory function. Islet iso-
lation and perifusion were performed to evaluate kinetics of insulin
release in vitro, especially first-phase insulin.
Results: In rhein-treated group, the blood glucose concentrations at
0 min, 60 min and 120 min after glucose load were significantly
reduced. Simultaneously measured insulin levels at 30 min and
60 min were significantly higher than those of control. Perifusion
showed that rhein-treated group manifested a significantly increase
of first-phase insulin secretion. Concurrently, rhein treatment greatly
preserved beta cell mass and inhibited beta cell apoptosis.
Conclusions: Rhein treatment significantly improved glucose toler-
ance by preservation of beta cell mass and inhibition of beta cell
apoptosis in db/db mice.
P21
Prevalence of obesity among adolescents
(10–14 years) in Kuwait
IF EL BAYOUMY
Ports and Borders Health Division, MOH, Kuwait
The purpose of this cross-sectional study was to find out the preva-
lence of obesity and overweight among intermediate school adoles-
cents aged 10–14 years. The study comprised a multistage stratified
random sample that included 5402 children (2657 males and 2745
females). They represent 12.7% of the total number of children
between 10 and 14 years during the educational year 2005–2006.
The weights and heights of adolescents were measured, from which
the body mass index (BMI) was calculated, which is the weight in
kilograms divided by the height in meters squared (kg/m2). BMI
values higher than 95 percentile were accepted as being obese and
those in between 85 and 94 percentile were accepted as overweight.
Dietary intake was assessed by the investigators using food exchange
lists designed by American Diabetic Association and physical fitness
was measured by modified Harvard step test. Data regarding
monthly income of the chosen sample were collected from parents of
those children. The overall prevalence of overweight and obesity in
adolescent Kuwaiti children aged 10–14 years was 30.7% and
14.6%, respectively. The overall prevalence of overweight and obesity
among males was 29.3% and 14.9%, respectively (P < .001) and
the prevalence of overweight and obesity among females was 32.1%
and 14.2%, respectively (P < .001). High daily caloric intake by the
obese and overweight children and physical inactivity was reported
among the majority of them. Health education programs should be
conducted to control this syndrome in order to prevent future risk of
obesity-related disease, and physical activity programs should be
incorporated in the schools. Any management plan for overweight
and obese children should include 3 major components: diets, exer-
cise, and family-based behavior and they should not be placed on
restrictive diets because adequate calories are needed for proper
growth.
P22
Effects of oral hypoglycemic drugs in
combination with antioxidant (honey) on
glycemic control and metabolic parameters in
streptozotocin-induced diabetic rats
OO EREJUWA1, SA SULAIMAN1, MS AB WAHAB1,
KNS SIRAJUDEEN2, S MD SALLEH3, S GURTU4
1Department of Pharmacology, School of Medical Sciences,
Universiti Sains Malaysia, Kelantan, Malaysia; 2Department of
Chemical Pathology, School of Medical Sciences, Universiti
Sains Malaysia, Kelantan, Malaysia; 3Department of
Pathology, School of Medical Sciences, Universiti Sains
Malaysia, Kelantan, Malaysia; 4School of Medicine and Health
Sciences, Monash University Sunway Campus, Jalan Lagoon
Selatan, Selangor, Malaysia
Diabetes mellitus is characterized by worsening glycemic control and
metabolic derangements. This study investigated the effects of addi-
tion of honey to hypoglycemic agents on glycemic control and meta-
bolic parameters in streptozotocin (STZ)-induced diabetic rats.
Diabetes was induced by STZ (60 mg/kg; ip). The diabetic rats were
randomly divided into six groups and administered distilled water,
honey, metformin, metformin and honey, glibenclamide or glibencla-
mide and honey. The rats were treated by gavage once daily for four
weeks. Hypoinsulinemia (0.27 ± 0.01 ng/mL), hyperglycemia
(22.4 ± 1.0 mmol/L) and increased fructosamine levels
(360.0 ± 15.6 lmol/L) were observed in the serum of diabetic rats.
Honey significantly increased insulin concentration, reduced hyper-
glycemia and fructosamine levels. Metformin or glibenclamide alone
significantly reduced hyperglycemia (13.2 ± 2.9 or
13.9 ± 3.4 mmol/L, respectively) in diabetic rats. However, addition
of honey to metformin or glibenclamide resulted in much lower
levels of blood glucose (9.9 ± 3.3 or 8.8 ± 2.9 mmol/L, respec-
tively). Similarly, honey combined with metformin or glibenclamide
produced significantly lower fructosamine levels (285.8 ± 22.6 or
301.3 ± 19.5 lmol/L, respectively). In contrast, metformin or glib-
enclamide alone did not decrease fructosamine (314.6 ± 17.9 or
330.0 ± 29.9 lmol/L, respectively). Besides, these drugs or their
combination with honey increased insulin. Metformin or glibencla-
mide combined with honey also significantly reduced the levels of
creatinine, bilirubin, triglycerides and VLDL cholesterol. This study
shows that addition of honey to hypoglycemic drugs further reduces
serum glucose and fructosamine and offers beneficial metabolic
effects, not achieved with either drug alone.
P23
Expressional regulation of the leptin and its
receptor by N-3 PUFAs is not related to the dna
methylation of their promoters in diet induced
obese mice
C FAN, X LIU, W SHEN, K QI
Beijing Pediatric Research Institute, Beijing Children’s Hospital,
Capital Medical University
In this study, we investigated the effects of dietary n-3 PUFAs on
methylation of CpG islands in the promoter regions of leptin, leptin
receptor (leptin-R) and pro-opiomelanocortin (POMC) genes, as well
as the effects of the n-3 PUFA status in early life on the DNA modifi-
cation of the three genes’ promoters. Male C57 BL/6J mice were fed
with four high-fat diets with different fat types – sunflower oil (n-3
PUFA deficient), soy oil, fish oil, and mixture of soy and fish oil (soy;-
fish oil = 1:1), with two low-fat diets – sunflower oil and soy oil as
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control. Female mice were fed with two breeding diets – sunflower
oil and mixture of soy and fish oil (soy;fish oil = 1:1) during preg-
nancy and lactation to breed new pups. Compared to the mice fed
with the control diets, the expressions of leptin in fats and leptin-R
and POMC in hypothalamus were increased in the DIO mice, and n-3
PUFAs in the DIO diets reversed their increased expressions. The
mean methylation level of CpG sites in the promoter regions of leptin
and POMC genes showed no differences between the DIO and the
control groups as well as between the n-3 PUFA containing and defi-
cient diet groups. For the CpG sites in the promoter regions of leptin-
R, no methylation was found both in all the DIO and the control
groups. Still feeding the mice with the n-3 PUFA diet during maternal
pregnancy and lactation did not affect CpG methylation in the leptin
and POMC promoters. Our findings indicate that the promoter DNA
methylation may not relate to the expressions of leptin, leptin-R and
its related hypothalamic neuropeptides POMC.
P24
Maternal leptin level as predictor marker in
gestational diabetis mellitus
AA FAWZY1, AT TAWFIK1, MS SWELEM1,
MM ELBERDENY2
1OB/GYN Dep., School of Medicine, Alexandria, Egypt;
2Clinical Pathology Department, School of Medicine,
Alexandria, Egypt
The objective of the study was to evaluate the role of Leptin as a pre-
dictor of gestational diabetes mellitus (GDM) and which precedes
first: changes in leptin or abnormal glucose metabolism.
Methods: Forty pregnant ladies were selected, divided into 2 groups:
G1 (study G): Twenty pregnant with GDM. G2 (Control G): Twenty
normal pregnant. All were subjected to Ultrasound scan, body mass
index (BMI), routine investigations, glucose challenge test (GCT),
oral glucose tolerance (OGT) and measurement of serum leptin level
at 16–20 and 24–28 gestational week.
Results: The leptin levels were significantly increased in G1 than G2
at different periods of gestation. The leptin levels changes happened
earlier than the increase of insulin resistance. Pregnant ladies that
developed GDM later had highest leptin level. Evident positive corre-
lations were found between leptin level at 24–28 weeks and the
levels of GCT OGT in G1, also, the same was observed with BMI at
different periods of gestation in G1.
Conclusion: This preliminary study, confirmed that, the increased
levels of leptin preceded the onset of abnormal glucose level in preg-
nant that developed GDM. This cytokine had a possible predictive
value in GDM diagnosis. The subject is still open for further assess-
ment, on larger number scale.
P25
Correlates of successful completion of the
chronic disease self-management program by
diabetics
SN FORJUOH1, JN BOLIN2, C HUBER3,
JW HELDUSER2, D BEGAYE1, J SCHIMANK2, MG ORY4
1Texas A&M HSC College of Medicine, Department of Family &
Community Medicine, Temple, Texas, USA; 2Texas A&M HSC
School Of Rural Public Health, Department Of Health Policy &
Management, College Station, Texas, USA; 3Texas A&M HSC
School Of Rural Public Health, Department Of Epidemiology &
Biostatistics, College Station, Texas, USA; 4Texas A&M HSC
School Of Rural Public Health, Department Of Social &
Behavioral Health, College Station, Texas, USA
Background: The Chronic Disease Self-Management Program
(CDSMP) is a 6-session workshop designed to address the need for
self-management education in persons with chronic disease, includ-
ing T2DM.
Purpose: To identify factors that may be associated with successful
completion of the CDSMP.
Methods: A survey of 113 patients with T2DM (HbA1c ‡7.5) in an
HMO. Survey questions included demographics, health-related quality
of life, physical activity measures, pain and fatigue, as well as diet,
exercise, home blood glucosemonitoring (HBGM), and foot care mea-
sures. Clinical data included height, weight, BMI and HbA1c. Success-
ful completionwas defined as attendance in at least 4 of 6 sessions.
Results: 71% of participants successfully completed the CDSMP.
There were no significant differences between completers and non-
completers with regard to age, race/ethnicity, gender, general health,
and responses to questions on physical activity, nutrition, HBGM, and
foot care. However, the average number of days/week that comple-
ters participated in self-care activities was greater than that for non-
completers for almost every positive self-care task including HBGM
(5.10 vs. 4.96), checking of feet (4.94 vs. 4.44), following a healthful
eating plan (3.98 vs. 3.48), spacing carbohydrates (3.65 vs. 2.80),
and participating in >30 min exercise (2.71 vs. 2.26), although not
significantly different.
Conclusion: Completion of the CDSMP was not found to be asso-
ciated with race/ethnicity or socioeconomic status¨ C factors that have
been linked to health disparities. Successful completion of the
CDSMP may therefore imply better adherence to diabetes self-care
activities, although this outcome needs to be explored further.
P26
Diagnostic value of chemical biomarkers in the
prediction of non alcolic steato hepatitis (NASH)
in diabetics’ mellitus patients with non-
alcoholic fatty liver disease
F GHARIBI1, S HASANI2, A SHARIFIAN3
1Kurdistan University of Medical Science, Sanandaj, Iran;
2Medical University of Kurdistan; 3Kurdistan Digestive Research
Center
Background: Liver biopsy is considered as the gold standard for
assessing non-alcoholic fatty liver disease (NAFLD) histological
lesions. The aim of this study was to determine the diagnostic utility
of non-invasive biochemical markers for prediction non alcoholic
steatohepatitis among diabetic mellitus type 2 patients with NAFLD.
Methods: 198 Diabetic mellitus type 2 patients were screened with
abdominal sonography to evaluate prevalence of NAFLD among
them .100 patients (51%) had NAFLD .finally? Thirty three patients
diagnosed with liver statuses by ultrsonographic examination partici-
pated in the study. accordig there liver biopsies? they had two
groups; simple statuses and NASH (Borderline and overt non alco-
holic steatohepatitis). chemical biomarkers results of them compare
with X2 and Fisher test.
Results: Twenty one patients (63.6%) had Non alcoholic steatohepa-
titis (NASH) consist of 9 patients with overt and 12 patients with Bor-
derline NASH and Twelve OF them (36.4%) had simple
steatosis.Average of AST in steatosis group was 23.6 and in NASH
group was 26.85 that not significant Average of ALT in steatosis
group was34.4 and in NASH group was 35.1 that not significant?
Average of GGTand ALP in steatosis group and NASH was not signifi-
cant. age ?BMI?Serum Cholestrol ?Serum triglyceride? total and
direct Billirubin had not significant differences amog them.
Conclusion: In Diabetic mellitus type 2 patients with NAFLD? bio-
chemical markers could not predicted non alcoholic steatohepatitis
from simple steatosis.
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Does exercise self-efficacy mediate the gender-
exercise maintenance relationship in coronary
heart disease patients with and without
diabetes?
SE GUO
Department of Nursing & the Chronic Diseases and Health
Promotion Research Center, Chang Gung Institute of
Technology, Taiwan
Background: The purpose of this study was to examine the determi-
nants of exercise maintenance during the 6 month period after com-
pletion of a cardiac rehabilitation (CR) program in patients with and
without diabetes.
Method: Subjects (n = 110) in this analysis were drawn from the
larger clinical study of adults who had completed a CR program after
myocardial infraction, coronary artery bypass graft surgery, and/or
angioplasty. Exercise maintenance, the total number of hours spent
exercising over the 6 month period, was collected using portable
wristwatch heart rate monitors (during exercise), and activity diaries
for 6 months. All data were collected and analyzed by hierarchical
multiple regression.
Results: The major determinants of exercise maintenance were
explained using factors from the Social Problem Solving Model when
controlling for covariates (age, race, education, retirement, co-mor-
bidity, and fitness). Hierarchical multiple regressions indicated exer-
cise self-efficacy and gender predicted statistically lifestyle exercise.
Twenty-two percent of the variance in exercise amount was
explained [F (9, 100) = 4.37, P < .001] by race, gender, education,
retirement status, diabetes status, fitness, pain, and self-efficacy. Exer-
cise self-efficacy was a significant mediator of the relationship
between gender and exercise maintenance. Diabetes, gender, and
exercise benefits/barriers associated with exercise self-efficacy after
control age, education, race, and pain.
Conclusions: Health care providers must be aware of the importance
of self-efficacy and employ techniques to increase it, thereby enhan-
cing exercise in CHD patients. Further research is needed to fully
understand exercise maintenance and self-efficacy in CHD population
with diabetes and among men and women.
P28
Efficacy of DPP-4 inhibitors and predictive factor
for the treatment in patients with type 2
diabetes mellitus
JR HAHM, SM LEE, TS JUNG, JH JUNG,
SI CHUNG
Department of Internal Medicine, Institute of Health Sciences,
Gyeongsang National University School of Medicine, Jinju city,
South Korea
Background: The object of study is to evaluate the efficacy of Dipep-
tidyl polypeptidase-IV inhibitors (DPP-4 inhibitors) to type 2 diabetes
patients who were not well controlled with other oral hypoglycemic
drugs or insulin, and to evaluate the predictive factors that influence
on glucose lowering effect.
Methods: Retrospective study of the efficacy of DPP-4 inhibitors was
done for whom diagnosed with type 2 diabetes patients, but not
reached glycemic control target (glycated hemoglobin >6.5%). I
evaluated the changes of glycated hemoglobin, fasting plasma glu-
cose, postprandial 1 h plasma glucose, and level of fasting plasma
C-peptide. I investigated diabetic microvascular complications at the
beginning of study.
Results: Total 156 patients were enrolled and followed up for
8.5 months. At the study end, patients receiving DPP-4 inhibitors
had a mean decrease in glycated hemoglobin of 0.67%, and in fasting
plasma glucose, and postprandial plasma glucose from baseline of 16
mg/dL, 32 mg/dL respectively (P < 0.005). Responders (n = 107,
68.6%) had features of short duration of diabetes (7.7 ± 7.1 years
versus 10.6 ± 6.8 years; P = 0.015), less microvascular complica-
tions, such as diabetic neuropathy (16.8% vs. 36.7%; P = 0.006)
compared to non-responders (n = 49, 31.4%).
Conclusion: A clinical meaningful improvement in glycemic control
to type 2 diabetes patients who were previously treated with other
oral hypoglycemic drugs or insulin was seen with concomitant DPP-4
inhibitors therapy. Patients who had short duration of type 2 diabetes
and who had no combined microvascular complication were more
easily achieved to glycemic target with concomitant use of DPP-4
inhibitors.
P29
Inhibitory potential of dietary fiber on key
enzymes of carbohydrate-lipid digestion and
absorption in pancreas of diabetes rats
K HAMDEN1, A ELFEKI2
1Biotechnology High School of Sfax (ISBS) Soukra, Tunisia;
2Animal Ecophysiology Laboratory, Faculty of Sciences of Sfax,
Tunisia
Diabetes is a serious health problem and a source of risk for numer-
ous severe complications such as obesity and cardiovascular diseases.
Treatment of diabetes and its related diseases can be achieved by sti-
mulating insulin secretion and/or activity and inhibiting key diges-
tives enzymes of oligosaccharides and lipid secreted by intestine.
Dietary fiber, was proven to possess interesting for the treatment of
diabetes and its complications. The findings revealed that Dietary
fiber as galactomanan considerable inhibited key enzymes-related to
diabetes responsible of conversion of oligosaccharides into simple
uptake sugars in pancreas such as alpha-amylase, maltase, lactase,
sucrase. Interestingly, fiber administration to surviving diabetic rats
inhibited considerable the key enzymes related to lipid digestion and
absorption as lipase and colipase in pancreas, which leads to notable
delay in the absorption of LDL-cholesterol and triglycerides and a
remarkable increase in HDL-cholesterol. Overall, the findings of the
current study indicate that galactomanan exhibit attractive properties
and strong potential and can, therefore, be considered a promising
candidate for future application as therapeutic agents in biotechnolo-
gical and bioprocess-based technologies, particularly those interested
in the development of anti-diabetic and hypolipidemic drugs.
P30
Comparative investigation of pioglitazone,
metformin and the combination of both as add-
on therapy in patients on high cardiovascular
risk despite stable insulin treatment with
insulin glargine
M HANEFELD1, I KLEINE2, A PFU¨TZNER3, W FUCHS2,
T FORST3
1GWT-TUD mbH - Centre for Clinical Trials; 2Takeda Pharma
GmbH; 3IKFE Mainz
Patients with long term type 2 diabetes with stable insulin therapy
still exhibit a high cardiovascular (CV) risk. We analyzed specific
effects of add on therapy with pioglitazone in comparison with met-
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formin and their combination in type 2 diabetes patients on high CV
risk, despite acceptable HbA1c control with basal insulin glargine. In
this double blind randomized active comparator controlled trial 121
patients with type 2 diabetes were included. Inclusions: stable insulin
treatment, HbA1c >6.5% < 8.5%, age 30–75 years. Patients: 63.0
(±7.5) years, BMI 32.2 (±5.3), HbA1c 7.34 (±0.53), insulin glar-
gine dosage 36.2 (±20.9) units. Comorbidities: hypertension 87.6%,
CVD 19%. After a run in phase of >2 weeks with glargine monother-
apy titrated to FBG<7.8 mmol/L patients were randomized to either
(A) bid 850 mg metformin (B) bid 15 mg pioglitazone or (C) 30 mg
pioglitazone plus 1.7 g metformin for a treatment of 6 months. Pri-
mary objective: MMP-9. These patients still exhibit an increased
inflammatory activity, hsCRP of 3.21 mg/L, MMP9 of >550 ng/mL
at baseline. Pioglitazone but not metformin significantly reduced
MMP-9 and hsCRP and increased insulin sensitivity and adiponectin
independent from glycemic control. All significantly reduced PAI-1.
The triple combination of pioglitazone with metformin resulted in
better HbA1c without added effect on inflammation and fibrinolysis.
No serious adverse events were observed. Weight change was -0.7 kg
vs. +4.3 kg vs. +2.7 kg and peripheral edema were observed in
11.9% vs. 40.0% vs. 20.5% in groups 1, 2 and 3. Pioglitazone is sug-
gested to be a rational add-on therapy to basal insulin in patients
with high cardiovascular risk because it closes a gap in prevention of
CVD by correction of increased inflammatory activity and insulin
resistance.
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The experience of bactericemia of type 2
diabetes mellitus in Northern Taiwan
JC HUANG1, YS PENG1, JH SUN2, YY HUANG2
1Chang Gung Memorial Hospital, Chiayi, Taiwan; 2Chang
Gung Memorial Hospital, Taoyuan, Taiwan
Background: More incidences with higher mortality rate of sepsis
made aggressive treatment in diabetes. We aimed to describe the
recent experience in Northern Taiwan.
Methods and Materials: Using the Taiwan Chang Gung Memorial
Hospital In-patient Diabetes Registry, hospitalized cases with type 2
diabetes mellitus were integrated with definite bactericemia. The
age, gender, hospital stay, organ system failure, complications and
comorbidities were analysis for mortality evaluation.
Results: The overall mortality rate is 13.0% and the most common
bacteria are Escherichia coli (E. coli). Comparing to else microorgan-
ism, the group presented older, female dominant, more comorbid-
ities, less failed organs, shorter hospital stay, and extremely low
mortality rate.
Discussion: The relative low mortality rate in patients with diabetes
was reconfirmed recently. The effects of E. coli on gender distribution,
length of hospital stay, and mortality need to be considered for clini-
cal practice.
Conclusion: The significant variation of mortality between common
pathogenic bacteria indicates the need of clinical practice remodeling.
P32
Effects of measures and policies based on
preventive guidance and intervention for the
metabolic syndrome
H IMAI, H NAKAO, F SATA
National Institute of Public Health, Japan
Objective: In Japan, measures were instituted via preventive gui-
dance and intervention for people with the metabolic syndrome
(METS) based on national lifestyle disease countermeasures from
2008. The objective of this research was to collect data from people
receiving health checks and investigate public guidance and interven-
tion to clarify results of this large-scale social experiment on public
health.
Method: Model prefectures were selected in regions throughout
Japan to avoid regional bias and data were collected from METS
patients and a reserve group in these prefectures. People who did or
did not receive health guidance and intervention were analyzed to
determine the effects such activities.
Results: This study was performed on 383,430 people from 40 to
74 years old examined for METS in 8 model prefectures. They
included 60,964 who received health guidance. To clarify effects of
preventive guidance and intervention, differences in changes in body
weights, waist size, blood glucose (HbA1c), triglycerides and blood
pressure for 2008 and 2009 were analyzed. Body weights dropped
by 2.4% in men and 3.0% in women. Other values also showed
decreases.
Discussion: Quantitative evaluation was performed on health gui-
dance in the first year of a new system of measures against lifestyle
diseases. Data were collected nationwide to avoid bias and the effects
of health guidance and intervention were examined. Prompt clarifi-
cation of these results is indispensable in validation of the new pre-
ventive measures. The results are highly useful for all persons related
to this system.
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Socioeconomic status and metabolic syndrome
among rural women of Bangladesh
AMS ISLAM1,2, S JESMIN1,2, MR ISLAM1,2, MS MIA1,2,
SN SULTANA1,2, S ZAEDI1,2, S KIMURA1
1National Center for Global Health and Medicine (NCGM),
Tokyo, Japan; 2Health and Diseases Research Center for Rural
Peoples (HDRCRP), Dhaka, Bangladesh
Background: Metabolic syndrome (MS) is now considered as a global
epidemic. Although, socioeconomic status (SES) has been identified
as an important determinant of health across a broad range of health
issues, however, no previous studies of MS so far have explicitly
examined the effect of SES in the Bangladeshi context. The purpose
of this study, thus, was to estimate the prevalence of MS and its asso-
ciation with the socioeconomic conditions in Bangladeshi rural
women.
Methods: A total of 1485 apparently healthy rural women aged
‡15 years were studied using a population based cross-sectional sur-
vey following the World Health Organization’s STEPS approach
(modified). Education, family income, land ownership and living
housing area were considered as indicators of SES.
Results: The prevalence of MS was 35.56. Higher prevalence was
found among the respondents with higher SES (MS vs. non-MS:
family income ‡140 USD 3.6% vs. 2.7%, family income 70–139 USD
21% vs. 15.5%, family income <70 USD 74.5% vs. 78%, P = 0.071;
family having land 71.8% vs. 52.3%, family having no land 26.6%
vs. 43.2%, P £ 0.001; family living area >1,000 sq. ft 84.4% vs.
70.5%, family living area £1,000 sq. ft 15.6% vs. 29.5%, P £ 0.001;
having formal education 43.3% vs. 50.4%, having no education
56.7% vs. 49.6%, P = 0.017).
Conclusions: MS was significantly more prevalent among upper SES
compared to lower SES which indicates SES as an emerging risk fac-
tor of MS in developing countries like Bangladesh which further calls
for a need of promoting health awareness and increasing healthy
rural amenities for prevention.
Copyrightª 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl. 2): 90–120.
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Prevalence of metabolic syndrome in pre- and
post- menopausal rural women of Bangladesh:
result from a population- based study
R ISLAM1,2, S JESMIN1,2, S MIA1,2, AMS ISLAM1,2,
SN SULTANA1,2, S ZAEDI1,2, A RAHMAN1,
N YAMAGUCHI2, M HIROE2, S KIMURA2
1Health and Diseases Research Center for Rural Peoples
(HDRCRP), Dhaka, Bangladesh; 2National Center for Global
Health and Medicine (NCGM), Tokyo, Japan
Background: Gender differences in prevalence and consequences of
the metabolic syndrome (MS) as a strong predictor of cardiovascular
disease (CVD) are challenging problems. Post-menopausal status
may explain in part the cause of acceleration of CVD with aging.
Aim: The present community-based, cross-sectional investigation
was aimed at identifying the principal components of risk variables
associated with the metabolic syndrome in pre-menopause and post-
menopausal Bangladeshi rural women.
Methods: This is a descriptive cross-sectional study carried out at
rural Bangladeshi women. Socio-demographic information, anthro-
pometric measurements and blood pressure were obtained from the
subjects in a standardized manner. Venous samples were collected
for necessary investigations and analyzed at the hospital central
laboratory.
Findings: 1802 subjects (1094 pre-menopause and 708 post-meno-
pause) with a mean age of 39.9 ± 13.9 (range 15–85) years were
studied. Prevalence of the modifiable cardiovascular risk factors
screened were as follows: generalized BMI ‡ 30 kg/m2 2.8% (pre-
menopause 3.0%, post-menopause 2.5%, P = 0.333), truncal obesity
8.4% (pre-menopause 8.4%, post-menopause 8.4%, P = 0.51),
hypertension 28.2% (pre-menopause 14.5%, post-menopause
49.4%, P < 0.001), elevated fasting blood glucose (‡6.1 mmol/L)
35.4% (pre-menopause 26.2%, post-menopause 49.6%, P < 0.001),
hypercholesterolaemia 35.5% (pre-menopause 32.8%, post-meno-
pause 39.7%, P = 0.002), elevated LDL-cholesterol 42.7% (pre-
menopause 41.5%, post-menopause 44.0%, P = 0.208), low HDL-
cholesterol 84.0% (pre-menopause 80.7%, post-menopause 87.3%,
P < 0.001), hypertriglyceridaemia 28.7% (pre-menopause 23.2%,
post-menopause 37.1%, P < 0.001), MS 25.8% (pre-menopause
17.4%, post-menopause 38.8%, P < 0.001) and atherogenic index
(HDLc/TC<0.18) 32.8% (pre-menopause 23.4%, post-menopause
42.2%, P < 0.001).
Conclusions: The prevalence of metabolic syndrome and the asso-
ciated modifiable cardiovascular risk factors were higher in post-
menopausal women compared to those in pre-menopausal women in
rural Bangladesh.
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Prevalence of metabolic syndrome among rural
Bangladeshi women
R ISLAM1,2, S MIA1,2, A RAHMAN1, SN SULTANA1,2,
R MAHMOOD1, AMS ISLAM1,2, S ZAEDI1,2,
N YAMAGUCHI2, M HIROE2, S KIMURA2, S JESMIN1,2
1Health & Diseases Research Center for Rural Peoples
(HDRCRP), Dhaka, Bangladesh; 2National Center for Global
Health and Medicine (NCGM), Tokyo, Japan
Objective: Metabolic syndrome (MS) is described as a cluster of
abnormalities that confers an increased risk of developing athero-
sclerotic cardiovascular diseases and also type 2 diabetes mellitus.
MS is now considered as a global epidemic; with current estimates
revealing that about 20–30% of the adult population worldwide is
affected by this syndrome. The purpose of the present study was to
assess the prevalence of metabolic syndrome - related disorders in
rural women of Bangladesh.
Methods: In the present study, a total of 1485 apparently healthy rural
Bangladesh women aged ‡15 years were studied using a population
based cross-sectional survey according to the World Health Organiza-
tion’s STEPS approach (modified). The prevalence of MS was esti-
mated using NCEPATP III, modified NCEPATP III and IDF criteria.
Results: The prevalence rates of MS were 25.05% (NCEP ATP III),
35.56% (modified NCEP ATP III), and 17.51% (IDF), as revealed by
the present study. Furthermore, 10.03% had excess waist circumfer-
ence, 29.43% had elevated blood pressure, 30.57% had elevated
fasting plasma glucose level, 85.05% had low HDL values and
26.87% had increased triglyceride values. Low plasma HDL level was
found to be the most common abnormality in this population. Ele-
vated waist circumference was the least frequent component.
Conclusions: The present study shows a high prevalence of MS and
its associated risk factors in rural Bangladeshi women. These findings
are important in that they provide insights that should be helpful in
formulating public health policy and in the development of future
health prevention strategies in Bangladesh.
P36
Assessing prevalence of metabolic syndrome
and association of this syndrome with coronary
heart disease (CHD) in patients were referred to
the heart center of Hamedan University of
Medical Science
L JAMSHIDI, A SEIF
Islamic Azad University, Hamedan Branch, Iran
Objective: The metabolic syndrome is a growing health problem in
the world. The metabolic syndrome, which consists of multiple inter-
related risk factors, increases the risk for atherosclerotic cardiovascu-
lar disease by 1.5–3 folds, and raises the risk for type 2diabetes by 3–
5 folds. It affects over 26 percent of adults, or over 50 million Ameri-
cans. Patients with metabolic syndrome (M.S) are known to be at
high risk for heart disease and diabetes. The aim of this study was,
Assessing prevalence of metabolic syndrome and association of this
syndrome with coronary heart disease in patients were referred to
the heart center of Hamedan University 1387.
Methods: A cross sectional study has been made with 1064 patient.
We examined all C.H.D patient (at total 514) attended in a heart cen-
ter during 3 month and 550 without CHD disease. Patients with 3 or
more of the following symptoms (NCEP & ATPIII criteria) are consid-
ered to have the Metabolic syndrome: abdominal obesity (waist
>102 cm for men; >88 cm for women), increased triglycerides
(>150 mg/dL); low HDL-C (<40 mg/dL in men; <50 mg/dL in
women), elevated blood pressure ‡130/‡85 mmHg, and a raised
fasting glucose (‡110 mg/dL).
Results: We have found significant differences between M.S and
C.H.D. The prevalence of M.S was 32.5 in patient and 21.3 in other
population. There were 46.3%women&53.7%men and 13.6% smok-
ing. Hypertriglyceridemia equal to or over 150 mg/dLwas 39.1%
Conclusion: The prevalence of M.S in the sample of C.H.D patient
was very high, and their correlation with other risk factors very sig-
nificant .Thus, the cardiovascular risk of this patient is very high.
Copyrightª 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl. 2): 90–120.
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Comparison of serum lipid levels in obese adult
in Hamedan, Iran, 2010
L JAMSHIDI, A SEIF
Islamic Azad University, Hamedan Branch, Hamedan, Iran
Obesity is a significant health crisis around the world. Of great con-
cern are the data pointing to the recent increase in the prevalence of
obesity irregardless of age group and country. A lipid disorder
increases risk for atherosclerosis, and thus for heart disease, stroke,
high blood pressure (hypertension), and other problems. Abnormal
cholesterol and triglyceride levels may also be caused by being over-
weight or obese.
Objective: The objective of this study was to quantify the prevalence
of overweight and obesity and Comparison of serum lipid levels in
adult.
Materials and methods: During in this study 1327 (721 male and
584 females) aged 24–60 years were studied. A questionnaire was
filled, and weight and height and WHR were measured. Plasma cho-
lesterol and triglyceride levels were measured after an overnight fast.
Discussions and conclusions: The body mass index (BMI) was calcu-
lated and adjusted for age and sex. Prevalence of overweight and
obesity were 41.8%. BMI increased with age, and it was higher in
those who had lower levels of physical activity. Increase of the serum
cholesterol, LDL, TG level was strongly associated with the abdom-
inal obesity. This study highlights the high prevalence of overweight
and obesity in adult in Hamedan.
P38
Sleep problems and weight gain in Iranian
adults
L JAMSHIDI, A SEIF
Islamic Azad University, Hamedan Branch, Iran
Objective: The prevalence of obesity is increasing at an alarming rate
in many parts of the world. Obesity is a significant health crisis
around the world. Individual and environmental factors that have an
influence on energy balance are not fully understood. Current treat-
ments for obesity have been largely unsuccessful in maintaining
long-term weight loss, suggesting the need for new insight into the
mechanisms that result in altered metabolism and behavior and may
lead to obesity. Parallel to an increase in body weight, one has also
observed a reduction in sleep times. The aim of this study was to
examine the Sleep problems and anthropometric factors (weight
gain) in Iranian adults, hamedan.
Materials and methods: A questionnaire was filled and weight, base-
line waist circumference measured. We examined association
between BMI and quality of sleep. Body composition measurements
and self-reported sleep duration were determined. Changes in adip-
osity indices were compared between short- (5–6 h), average- (7–
8 h), and long- (9–10 h) duration sleeper groups. After adjustment
for age, sex, and baseline body mass index, short-duration sleepers
gained 2.24 kg more and long-duration sleepers gained 1.37. Short-
and long-duration sleepers were 34.2% and 11.7% more likely to
experience a 5 kg weight gain. The risk of developing obesity was
elevated for short- and long-duration sleepers as compared with aver-
age-duration sleepers.
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Circulating levels of VEGF and its receptors,
sVGEF-R1 and sVEGF-R2 in metabolic syndrome
in Bangladeshi rural women
S JESMIN1,2, N YAMAGUCHI2, R ISLAM1,2, S MIA1,2,
AMS ISLAM1,2, SN SULTANA1,2, S ZAEDI1,2,
M MOROI2, M HIROE2
1Health and Diseases Research Center for Rural Peoples
(HDRCRP), Dhaka, Bangladesh; 2National Center for Global
Health and Medicine (NCGM), Tokyo, Japan
Objective: Metabolic syndrome (MS) is associated with impaired
angiogenesis where vascular endothelial growth factor (VEGF) plays
a key role in angiogenesis through binding to its specific receptor,
sVEGF-R1 and sVEGF-R2. The purpose of the present study was to
assess circulating levels of VEGF, sVEGF-R1, and sVEGF-R2 in sub-
jects with Metabolic Syndrome (MS) or without metabolic syndrome
(non-MS) and further examined their association with clinical and
metabolic parameters.
Methods and results: A total of 1485 rural Bangladeshi women aged
‡15 years were studied using a population based cross-sectional sur-
vey. The prevalence rates of MS were 25.05% (NCEP ATP III). VEGF
levels were significantly increased in MS subjects (MS vs. non-MS:
575 vs. 490, P < 0.001). There were no significant relation of
sVEGF-R1 and sVEGF-R2 with MS (sVEGF-R1, MS vs. non-MS: 446
vs. 667, P = 0.093; sVEGF-R2, MS vs. non-MS: 8943 vs. 9400,
P = 0.0.344). In multivariable analyses, we found that VEGF had
significant positive associations with fasting blood glucose
(r = 0.181, P < 0.001), BMI (r = 0.143, P < 0.001), cholesterol
(r = 0.101, P < 0.001), non-HDL cholesterol (r = 0.091,
P < 0.001), LDL cholesterol (r = 0.079, P = 0.007), insulin(r =
0.075, P = 0.022), DBP (r = 0.064, P = 0.025) and SBP
(r = 0.057, P = 0.048) even after adjusting for age. Multiple regres-
sion analysis revealed that fasting blood glucose (beta = 0.158,
P = 0.001) and BMI (beta = 0.083, P = 0.017) were independent
determinants of VEGF. We also found that mean VEGF levels
increased in proportion to the accumulation of components of MS.
Conclusions: The correlation of VEGF needs further investigations to
define the clinical utility and predictive value of serum VEGF levels
in MS.
P40
Clinical characteristics of patients with
rambdomyolysis in hyperglycemic emergency
states
TS JUNG, JR HAHM
Department of Internal Medicine, Institute of Health Sciences,
Gyeongsang National University School of Medicine, Jinju city,
South Korea
Objective: The purpose of this study was to investigate the preva-
lence of rhabdomyolysis in a hyperglycemic emergency state and its
significance on the clinical course and prognosis of patients with
hyperglycemic emergency state.
Patients and Methods: We reviewed medical records of hyperglycemic
emergency patients who were checked serum creatine kinase levels
from May 2003 to April 2010. We assessed clinical characteristics,
biochemical profiles, and clinical course of the patients and analyzed
according to the occurrence of rhabdomyolysis.
Results: The prevalence of rhabdomyolysis was 27.1% (n = 36)
among 133 patients. Patients with rhabdomyolysis had higher rates
of hemodialysis and mortality than those without rhabdomyolysis.
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The factors associated with rhabdomyolysis in hyperglycemic emer-
gency state were increased serum anion gap and serum creatinine
(P < 0.05).
Conclusion: Rhabdomyolysis was commonly combined with hyper-
glycemic emergency state and this aggravated clinical course and
increased mortality. Our results suggest that rhabdomyolysis in
hyperglycemic emergency is associated with increased serum anion
gap and serum creatinine on admission.
P41
Diabetes clinical model in remote area
MS KAMEL
Internal Medicine Department, Minia University, Egypt
Control of diabetes mellitus is a high priority for primary health care
systems. One innovative method of diabetes care delivery is the use of
structured diabetes care in primary care. This includes the use of
chronic care diabetes clinics or mini-clinics operated by general practi-
tioners in primary care. There is limited experience with this model in
non-Western settings. This study sought to evaluate a multi-compo-
nent structured approach to diabetes care in primary care including
chronic care diabetes clinics in a rermote area. A multifaceted inter-
ventionwas initiated in the diabetes clinic composed of a diabetic flow
chart, and educational programs for clinic nurses, doctors and
patients. The study intervention took place over a period of 24 months
with the diabetic outcomes (fasting blood glucose,HBA1C, BMI, blood
pressure, renal functions, fundus examination, lipid profile and CVS
morbidity and mortality) and adherence to follow-up appointments.
Knowledge and satisfaction questionnaires were also administered to
patients. A new diabetes clinic was established in One-day surgery
hospital, Samalout, Minia Governorate, 250 km south to Cairo. It was
designed as a structured diabetes care with a complex intervention
comprising diabetes registry, patient education, educated diabetes
nurse, local clinical protocol and structured communication across the
primary-secondary care interface.
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Independent association of TG/HDL-C with
urinary albumin excretion in normotensive
subjects in a rural Korean population
JK KIM1, HT KANG1,2, JY KIM3, J LIMTON4,
JH YOON5,6, SB KOH5,6,7
1Department of Family Medicine, Wonju College of Medicine,
Yonsei University, Wonju-city, Gangwon-do, South Korea;
2Department of Medicine, Graduate school of Yonsei University,
Seoul, South Korea; 3Division of Cardiology, Department of
Internal Medicine, Wonju College of Medicine, Yonsei
University, Wonju-city, Gangwon-do, South Korea;
4International Health Care Center, Severance Hospital, College
of Medicine, Yonsei University, Seoul, South Korea;
5Department of Preventive Medicine, Wonju College of
Medicine, Yonsei University, Wonju-city, Gangwon-do, South
Korea; 6Department of Environmental and Occupational
Medicine, Wonju College of Medicine, Yonsei University, Wonju-
city, Gangwon-do, South Korea; 7Institute of Genomic Cohort,
Wonju College of Medicine, Yonsei University, Wonju-city,
Gangwon-do, South Korea
Background and Aims: Dyslipidemia is associated with renal dysfunc-
tion and cardiovascular diseases. The ratio of triglycerides (TG, mg/
dL) to high-density lipoprotein cholesterol (HDL-C, mg/dL) is a reli-
able indicator of insulin resistance and atherosclerotic diseases. The
purpose of this study was to examine the association between TG/
HDL-C and albuminuria in rural Korean adults.
Methods and Results: This cross-sectional study included 9,094 adult
subjects (4,091 men, 5,003 women) who were enrolled in the Kor-
ean Genomic Rural Cohort (KGRC) and aged 40 years or more. Albu-
minuria was defined as a urine albumin/creatinine ratio (UACR)
¡ 30 mg/g. Participants were categorized into quartile groups by TG/
HDL-C for comparison. Median UACR and albuminuria prevalence
increased in a linear fashion in both genders according to TG/HDL-C
quartile. Compared to the lowest quartile of TG/HDL-C (<1.94 in
men, <1.71 in women), the odds ratios (ORs) for albuminuria in
participants who were categorized in the highest quartile of
TG/HDL-C (¡ 4.98 in men, ¡ 4.20 in women) were 1.30 (95% confi-
dence interval (CI), 0.97¨C1.75) and 1.36 (1.03¨C1.79) in men
and women, respectively, when adjusted for age, systolic blood pres-
sure, and other covariates. In normotensive men and women, the
ORs for albuminuria in the highest TG/HDL-C quartile were 1.58
(1.04–2.39) and 1.68 (1.15–2.45), respectively, even after full adjust-
ment. In contrast, TG/HDL-C was not associated with albuminuria in
hypertensive subjects.
Conclusions: TG/HDL-C was independently associated with
increased prevalence of albuminuria in normotensive rural Korean
subjects aged 40 years or more in KGRC.
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Insulin resistance, inflammation, and
nonalcoholic fatty liver disease in the
metabolically healthy and non-obese adults
over 50 years
S KIM, J CHOI, M KIM
Department of Family Medicine, Konkuk University Medical
Center, Konkuk University School of Medicine, Seoul, Korea
Objective: The aim of this study is to examine the association of insu-
lin resistance and inflammation with NAFLD in metabolically healthy
and non-obese adults over 50 years.
Materials/Methods: This was a cross sectional study of 759 subjects
who were aged 50 years and older. Diagnosis of NAFLD was based
on sonographic evidence of fatty liver without significant alcohol
consumption and other cause of chronic liver disease. We defined
metabolically healthy subjects as having nothing of metabolic compo-
nents: high blood pressure (‡130/85 mmHg), elevated fasting glu-
cose (‡100 mg/dL), hypertriglyceridaemia (‡150 mg/dL), low high
density lipoprotein-cholesterol (men, <40 mg/dL; women,
<50 mg/dL), and abdominal obesity measured by a waist circumfer-
ence of ‡90 cm for men and ‡80 cm for women. High sensitivity C-
reactive protein (hs-CRP), homeostasis model assessment of insulin
resistance (HOMA-IR), and uric acid were divided into quartile
groups. We computed odds ratios (OR) for each quartile relative to
the lowest quartile group.
Results: After adjusting for age, sex, smoking status, regular exercise,
hs-CRP, HOMA-IR, and uric acid, significant association was found
between NAFLD and higher levels of hs-CRP, HOMA-IR, and uric
acid. After adjusting for age, sex, smoking status, regular exercise, hs-
CRP, HOMA-IR, and uric acid, the ORs(95% confidence interval) of
NAFLD with the highest quartile of hs-CRP, HOMA-IR, and uric acid
comparing the lowest quartile of them were 2.58(1.03–6.50),
2.55(1.08–6.05), and 5.15(1.78–14.89), respectively.
Conclusions: Insulin resistance and inflammation are associated
with NAFLD in metabolically healthy and non-obese adults over
50 years.
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Effects of fenofibrate therapy on circulating
adipocytokines in patients with primary
hypertriglyceridemia
K KOH1, M QUON2
1Gachon University Gil Hospital; 2Diabetes Unit, NIH, USA
Background: Adipocytokines including adiponectin and leptin may
serve important roles in linking metabolic signals, inflammation, and
atherosclerosis. We investigated effects of fenofibrate therapy on
endothelial dysfunction and adipocytokine profiles.
Methods: A randomized, single-blind, placebo-controlled, cross-over
study was conducted in 53 patients with primary hypertriglyceride-
mia. We administered placebo or fenofibrate 200 mg daily for
8 weeks.
Results: When compared with placebo, fenofibrate therapy decreased
non-HDL cholesterol, apolipoprotein B, and triglycerides while
increasing HDL-cholesterol and apolipoprotein A-I (all P < 0.001)
and decreasing total cholesterol (P < 0.05). Moreover, fenofibrate
therapy substantially improved the percent flow-mediated dilator
response to hyperemia by 55 ± 7% (P < 0.001), lowered plasma
levels of fibrinogen and TNF-a by 9 ± 2% (P < 0.001) and 6 ± 3%
(P = 0.014), respectively, and lowered hsCRP from 1.10 to 0.90 mg/
L (P = 0.004). When compared with placebo, fenofibrate therapy
increased plasma levels of adiponectin by 17 ± 4% (P = 0.001),
insulin sensitivity by 4 ± 1% (as assessed by QUICKI, P = 0.009),
and decreased plasma levels of leptin and resistin by 4 ± 7%
(P = 0.022) and 10 ± 3% (P = 0.001), respectively. There were
correlations between percent changes in QUICKI and percent
changes in adiponectin levels (r = 0.279, P = 0.043) or leptin
(r = -0.280, P = 0.042).
Conclusions: Fenofibrate therapy significantly improved percent
flow-mediated dilator response to hyperemia, reduced pro-inflamma-
tory biomarkers, and improved adipocytokines levels and insulin sen-
sitivity in hypertriglyceridemic patients. Thus, actions of fenofibrate
to regulate adipocytokine levels may be linked to beneficial effects
on pro-inflammatory status that simultaneously improve both
endothelial and metabolic function in patients with primary hypertri-
glyceridemia.
P45
Quercetin/adenosine combination induced
insulin resistance in high fat diet-fed mice
CY LEE
Monash University, Sunway Campus
Food-drug or food-food interactions refer to a situation whereby one
or more substances alter(s) the bioavailability or the clinical effective-
ness of the other substance when they are being taken concomitantly.
Both quercetin and adenosine are plant constituents reported to be
effective in improving dyslipidemia. This study looked at the summa-
tive effect of these two compounds in high fat diet-induced obesity.
C57BL/6 mice were divided into five groups, and each group was fed
with the following diet: low fat diet or control (C); high fat diet
(HF); high fat diet +0.8% quercetin incorporated into drinking water
(Q); high fat diet +0.01% adenosine in water (A); and high fat diet
+0.8% quercetin +0.01% adenosine, both compounds dissolved in
water (QA). Results showed that quercetin in the presence of adeno-
sine (QA), was not effective in preventing body weight gain and
adiposity. QA potently kept the plasma glucose and adiponectin at
basal levels, but significantly elevated insulin level, implying the
onset of insulin resistance (IR). Adenosine and quercetin, which
separately up-regulated endothelial nitric oxide synthase (eNOS)
expression, caused a distinctive reduction of eNOS expression when
given as a mixture to mice. As reported, IR led to the impairment of
insulin-induced eNOS activation. Quercetin per se did not have any
effect on liver fatty acid-binding protein (LFABP) expression. How-
ever, quercetin together with adenosine, have down-regulated LFABP.
In conclusion, there was no beneficial effect of consuming two com-
pounds which individually claimed to improve metabolic syndrome
parameters.
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The effects of complex exercise training on
muscle strength and endurance of lower-
extremity, balance and gait abilities in elderly
people with diabetes mellitus: a randomized
controlled trial
SW LEE
Department of Physical Therapy, Sahmyook University, Seoul,
Korea
Older people with diabetes mellitus and neuropathy have a
decreased balance and gait abilities. Lower-extremity exercise and
balance training increase physical performance in some older adults.
Complex exercise training designed to increase physical performance.
The purpose of this study was to assess the effects of complex exer-
cise training on muscle strength and endurance of lower-extremity,
balance and gait ability in older people with diabetes mellitus. We
conducted a randomized controlled trial involving 39 community-
dwelling individuals older than 65 years, who have a diabetes melli-
tus. They were randomly assigned to an intervention group (n = 19)
and control group (n = 20). The intervention was an 8 weeks com-
plex exercise training program composed of resistance training and
balance training by using elastic band and balance pad. Control
group executed no physical training program. Both group had the
education of physical health. Outcome measures were muscle
strength and endurance of lower-extremity, balance and gait abilities.
After a completion of training, there were significantly increased by
complex exercise that the strength of knee extension and ankle dorsi-
flexion, muscle endurance, balance ability, and gait ability (P < .05).
Interaction between group and time had a significant effect on the all
factors except for step and stride length (P < .05). In conclusion, the
complex exercise training improved lower legs muscle strength, mus-
cle endurance, balance and gait ability in elders with diabetes melli-
tus. These results suggest that elders with diabetes mellitus will be
prevented about risk of a fall at all by complex exercise training.
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P47
Dietary animal and plant protein intake and the
associations with overweight and obesity
indicators in European adolescents: the Helena
study
Y LIN1, I HUYBRECHTS1, M GONZALES2,
M KERSTING3, C OTTEVAERE1, C VEREECKEN1,
T MOURATIDOU4, E GRAMMATIKAKI5, G FREDERIC6,
M FERRARI7, L HALSTRO¨M8, M SJO¨STRO¨M9,
S GOMEZ10, L ESPERANZA10, D MOLNA´R11,
LA MORENO4, SD HENAUW1,12, ON BEHALF OF THE
HELENA CONSORTIUM
1Unit Nutrition and Food Safety, Department of Public Health,
Faculty of Medicine and Health Sciences, Ghent University,
Ghent, Belgium; 2Institut fu¨r Erna¨hrungs- und
Lebensmittelwissenschaften – Erna¨hrungphysiologie, Rheinische
Friedrich Wilhelms Universita¨t, Germany; 3Research Institute of
Child Nutrition Dortmund, Rheinische Friedrich-Wilhelms-
Universita¨t Bonn, Germany; 4GENUD (Growth, Exercise,
Nutrition and Development) Research Group, University of
Zaragoza, Zaragoza, Spain; 5Dietician- Public Health
Nutritionist, Research Associate Department of Nutrition and
Dietetics, Harokopio University, Greece; 6Faculte´ de me´decine,
University of Lille 2, Lille, France; 7Istituto Nazionalen di
Ricerca per gli Alimenti e la Nutrizione, Italy; 8Karolinska
Institutet, Sweden; 9Department of Biosciences and Nutrition,
Karolinska Institutet, Sweden; 10Consejo Superior de
Investigaciones Cientı´ficas, Spain; 11Pe´csi
Tudoma´nyegyetem,University of Pe´cs, Hungary; 12University
College Ghent, Department of Nutrition and Dietetics, Faculty
of Health Care Vesalius, Ghent, Belgium
Objectives: To evaluate dietary animal and plant protein intakes in
European adolescents, and to investigate the associations with
anthropometry (BMI z-score, Body fat percentage (BF%)).
Methods: 1804 (47% males) European adolescents (Austria,
Belgium, France, Germany, Greece, Italy, Spain and Sweden) aged
12.5–16.5 years completed two non-consecutive computerized 24 h
dietary recalls. Mixed linear model analysis was used to investigate
the association between animal and plant protein intakes and anthro-
pometry.
Results: Mean animal protein intake (58 g/d) contributed most to
total protein intake (96 g/d). Animal and plant protein intakes were
significantly lower in females than males (P < 0.001 for both). The
younger age-group (12.5–14.9) consumed significantly less plant
protein than the older age-group (15.0–16.9 years) (P < 0.001).
Furthermore, mixed linear model analysis showed that intakes of
total, animal and plant protein were inversely associated with BF%
(b = -0.467, P < 0.001; b = -0.197, P = 0.034; b = -0.237,
P < 0.001, respectively). However, no significant associations were
found between total, animal, plant protein intakes and BMI z-scores.
Conclusion: Total, animal and plant protein intakes might decrease
the obesity risk of European adolescents via improvement of body
composition.
P48
Dietary fibre intake and the associations with
overweight and obesity indicators in European
adolescents: the Helena study
Y LIN1, I HUYBRECHTS1, M GONZALES2,
M KERSTING3, T DE VRIENDT1, C VEREECKEN1,
T MOURATIDOU4, E GRAMMATIKAKI5, G FREDERIC6,
E TOTI7, L HALSTRO¨M8, M SJO¨STRO¨M9, J WARNBERG10,
S GOMEZ10, D MOLNA´R11, LA MORENO4,
S DE HENAUW1,12, ON BEHALF OF THE HELENA
CONSORTIUM
1Unit Nutrition and Food Safety, Department of Public Health,
Faculty of Medicine and Health Sciences, Ghent University,
Ghent, Belgium; 2Institut fu¨r Erna¨hrungs- und
Lebensmittelwissenschaften – Erna¨hrungphysiologie. Rheinische
Friedrich Wilhelms Universita¨t, Germany; 3Research Institute of
Child Nutrition Dortmund, Rheinische Friedrich-Wilhelms-
Universita¨t Bonn (Germany); 4GENUD (Growth, Exercise,
Nutrition and Development) Research Group, University of
Zaragoza, Zaragoza, Spain; 5Dietician- Public Health
Nutritionist, Research Associate Department of Nutrition and
Dietetics, Harokopio University, Greece; 6Faculte´ de me´decine,
University of Lille, Lille, France; 7Istituto Nazionalen di Ricerca
per gli Alimenti e la Nutrizione, Italy; 8Karolinska Institutet,
Sweden; 9Department of Biosciences and Nutrition, Karolinska
Institutet, Sweden; 10Consejo Superior de Investigaciones
Cientı´ficas, Spain; 11Pe´csi Tudoma´nyegyetem, University of
Pe´cs, Hungary; 12University College Ghent, Department of
Nutrition and Dietetics, Faculty of Health Care Vesalius, Ghent,
Belgium
Objectives: To evaluate total dietary fibre (DF) intake in European
adolescents, and to investigate the associations between total, water-
soluble and water-insoluble DF intakes and anthropometry (BMI
z-score and Body fat percentage (BF%)).
Methods: 1804 (47% males) European adolescents (Austria, Bel-
gium, France, Germany, Greece, Italy, Spain and Sweden) aged 12.5–
16.5 years completed two non-consecutive computerized 24 h diet-
ary recalls. Mixed linear model analysis was used to investigate the
association between total, water-soluble and water-insoluble DF
intakes and anthropometry.
Results: Mean intake of DF (20 g/d) was significantly lower in
females and the younger age-group (12.5–14.9) than in males and
the older age-group (15.0–16.9 years) (P < 0.001for both). How-
ever after adjustment for energy intake, DF intake was significantly
lower in males (7.8 g/(d*1000kcal) than in females (8.9
g/(d*1000kcal) (P < 0.001). In addition, obese subjects were
observed to have the lowest energy-adjusted DF intake (8.1
g/(d*1000kcal)). Furthermore, mixed linear model analysis showed
that total, watersoluble and water-insoluble DF intakes, were inver-
sely associated with BF% (b = -0.117, P < 0.001; b = -0.028,
P = 0.002; b = -0.091, P < 0.001, respectively). However, no sig-
nificant associations were found between total, water-soluble and
water-insoluble DF intakes and BMI z-score.
Conclusion: Total, energy-adjusted, water-soluble and water-insolu-
ble DF might play a role in the prevention of obesity in European
adolescents by improving body composition.
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Can mind-body movement therapy combat
central obesity and other indicators of
metabolic syndrome - promising findings from
recent clinical trials
X. LIU1,2, Y.D. MILLER3, N.W. BURTON1, J-H CHANG1,
W.J. BROWN1
1School of Human Movement Studies, The University of
Queensland, Australia; 2Centre for Integrative Clinical and
Molecular Medicine, School of Medicine, The University of
Queensland, Australia; 3School of Psychology, The University of
Queensland, Australia
Introduction: Metabolic syndrome is now recognized as a strong pre-
dictor of life threatening diseases such as diabetes, cardiovascular dis-
ease and stroke. There is growing evidence to suggest that mind-
body movement therapy (Tai Chi/Qigong) may improve indicators of
metabolic syndrome in people with diabetes. The aim of this study
was to assess the efficacy of Tai Chi/Qigong on central obesity and
other indicators of metabolic syndrome in adults with raised blood
glucose levels.
Methodology: A 12 week single-group pre-post feasibility study of 11
participants (3 male and 8 female; mean age = 56 years) with raised
blood glucose levels was first conducted to assess the feasibility and
acceptability of the intervention program, followed by a 12 week ran-
domized controlled trial. The randomized controlled trial involved
41 participants (16 male and 25 female; mean age = 59 years) with
pre-diabetes or type 2 diabetes, recruited from the local community.
The 41 participants were randomly allocated to an intervention (n =
20) or usual medical care control group (n = 21). Intervention group
participants attended a 12-week Tai Chi/Qigong training program.
Indicators of metabolic syndrome (body mass index, waist circumfer-
ence, systolic and diastolic blood pressure, fasting blood glucose, tri-
glycerides, and HDL-C) were assessed immediately prior to and after
the 12 week intervention in the two clinical trials.
Results: The feasibility study demonstrated that the 12 week inter-
vention showed significant improvements in four of the seven indica-
tors of metabolic syndrome including body mass index (mean
difference = -1.05, 95% CI = -1.48; )0.63, p < 0.001), waist circum-
ference (mean difference = )2.80 cm, 95% CI = )4.97; )0.62, p <
0.05), and both systolic (mean difference = )11.64 mm Hg, 95% CI
= )19.46; )3.51, p < 0.01) and diastolic blood pressure (mean dif-
ference = )9.73 mm Hg, 95% CI = )13.58; )5.88, p < 0.001).
There were also downward trends in the three haematological mea-
sures. The proportion of study participants with metabolic syndrome
decreased from 64% to 36%. Overall, the acceptability of interven-
tion program was found to be high with good adherence in the feasi-
bility study.
Linear regression analyses of the randomized controlled trial
showed that there were significant improvements in body mass index
and waist circumference in the intervention group, compared with
the control group (body mass index: between-group mean difference
= )1.17, 95%CI = )1.66; )0.67, p < 0.001; waist circumference:
between-group mean difference = )4.78 cm, 95%CI = )6.36;
)3.20, p < 0.001). There were also a significant improvement in fast-
ing blood glucose (mean difference = )0.47 mmol/L, 95% CI =
)0.79; )0.14, p < 0.01) and a trend towards significant improve-
ment in triglycerides (mean difference = )0.25 mmol/L, 95%CI =
)0.55; 0.04, p = 0.090) in the intervention group, but not observed
in the control group.
Conclusions: The findings provide grounds for cautious optimism in
relation to the role of the mind-body movement therapy in the pre-
vention and management of indicators of metabolic syndrome. Lar-
ger controlled studies are now required to confirm these preliminary
findings.
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Does the ckd epidemiology collaboration
(CKD-EPI) equation perform better than the
modification of diet in renal disease (MDRD)
study equation for estimating GFR levels abos
60 mL/min/1.73m2 in subjects with diabetes?
RJ MACISAAC1,2,3, K CHEONG2, E EKINCI2,
S VERMA2, E PREMARATNE2, G JERUMS2,3
1Department of Endocrinology and Diabetes, St. Vincent’s
Hospital, Fitzroy, Australia; 2Endocrine Centre, Austin Health,
Heidelberg West, Australia; 3University of Melbourne, Australia
Background: The MDRD equation underestimates reference GFR
levels > 60 mL/min/1.73m2 whereas GFR levels estimated from the
CKD-EPI equation are generally reported to be less biased. However,
for subjects with diabetes the relative performance of the CKD-EPI
and MDRD equations remains to be defined. We assessed the perfor-
mance of the CKD-EPI and MDRD equations for estimating GFR
(eGFR) compared with reference GFR measurements >60 mL/min/
1.73m2 in subjects with diabetes.
Methods: In a cross-sectional study of 199 consecutive clinic patients
with diabetes, a reference GFR was measured using 99mTc-DTPA
plasma clearance (iGFR). The mean iGFR was 80 ± 2.2 mL/min/
1.73m2 (mean ± SEM) and there were 139 subjects with a GFR
>60 mL/min/1.73m2. The bias (iGFR – eGFR) for the CKD-EPI and
MDRD equations was compared.
Results: In the subgroup of subjects with an iGFR >90 mL/min/
1.73m2 (mean GFR 112 ± 2.0, n = 76) both equations significantly
underestimated iGFR to a similar extent, CKD-EPI (-12 ± 1.4 mL/
min/1.73m2, P < 0.001) and MDRD (-11 ± 2.6 mL/min/1.73m2,
P < 0.001). In contrast, in the subgroup of subjects with an iGFR 60
to 89 mL/min/1.73m2 (mean GFR 77 ± 1.2, n = 59) the CKD-EPI
equation significantly overestimated iGFR values (+5.5 ± 1.5 mL/
min/1.7 m2, P < 0.001) whereas the MDRD equation did not
(+4.3 ± 1.9 mL/min/1.73m2).
Conclusions: The CKD-EPI equation does not improve the bias of the
MDRD equation when estimating GFR in subjects with diabetes and
a reference GFR measurement >60 mL/min/1.73m2. Both equations
significantly underestimate reference GFR levels > 90 mL/min/
1.73m2.
P51
BMI estimation from waist measurement, neck
circumference, mid-upper arm circumference
and epworth sleepiness scale
AR MARSHALL1, N HBOUBI2, S JONES3
1Cardiff University, Cardiff, UK; 2Neville Hall, Abergavenny,
UK; 3Blaenau Gwent Weight Management, Blaenau Gwent, UK
Objectives: 1) To investigate whether waist, mid-arm and neck cir-
cumference, and the Epworth sleepiness scale can be used to accu-
rately estimate BMI, 2) To determine whether patients have a
preference between anthropometric measuring or weighing.
Method: Data was collected from 74 obese patients, recruited via
Blaenau Gwent weight management clinic and 28 participants of a
control group (BMI 18–30). Data collected included waist and height
measurement, weight, mid-upper arm (MUAC) and neck circumfer-
ence (NC), Epworth sleepiness score and any preference indicated
when asked, between anthropometric measurement and traditional
weighing to estimate BMI.
Both groups were separated into sex. Using formulaic rearrange-
ment and trend analysis an equation (the H-M formula) was devised
to estimate BMI for both groups of participants using the data col-
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lected minus weight. This estimation was then compared against
BMI calculated in the traditional method.
Results: BMI can be accurately estimated from waist, MUAC and NC
collectively using the sex adjusted H-M formula. BMI did not
correlate with Epworth sleepiness scores. Most patients have no pre-
ference as to whether they are weighed or body measurements taken.
Conclusions: The H-M formula is a cost-effective, quick, portable,
non-invasive method to estimate BMI that can be used in patients
who are unable or unwilling to be measured in the traditional way.
P52
Level of tnf-a in metabolic syndrome in
Bangladeshi rural women
S MIA1,2, S JESMIN1,2, R ISLAM1,2, AMS ISLAM1,2,
SN SULTANA1,2, S ZAEDI1,2, N YAMAGUCHI2,
M HIROE2
1Health and Disease Research Center for Rural Peoples, Ena
Arista, Baitul Aman Housing Society, Adabor, Bangladesh;
2National Center for Global Health and Medicine, Toyama,
Shinjuku-ku, Tokyo, Japan
Among many inflammatory markers, tumor necrosis factor-alpha
(TNF-a) emerged as a key cytokine that influences intermediary
metabolism that play a great role in the development of dyslipidemia
and insulin resistance as important features of the metabolic syn-
drome, which may eventually augment the risk of cardiovascular dis-
eases and type 2 Diabetes Mellitus (DM). TNF-a has been
demonstrated to directly interfere with the metabolic pathways of tri-
glyceride and cholesterol. Therefore, TNF-amay gain a special impor-
tance when referring to atherosclerotic lesion development and the
risk of acute cardiovascular events. The aim of the study was to
observe the emergence of TNF-a level in subjects with and without
Metabolic Syndrome (MS) in rural women of Bangladesh. The study
subjects were recruited from the active participation of rural women
of northern side in Bangladesh. Group 1 consisted of subjects without
MS (non- MS) (n = 319) and group 2 consisted of subjects with MS
(n = 380). MS was defined using the modified National Cholesterol
Education Program Adult Treatment Panel (NCEP ATP III) criteria
according to the World Health Organization Asia Pacific guidelines.
The study revealed that average TNF-a level appeared as high in
metabolic syndrome 8.9 ± 0.24 (mean ± SE) with compare to non
metabolic syndrome (7.7 ± 0.32, P = 0.006). It also showed that
mean TNF-a increased with the increase of number of metabolic syn-
drome components. Body mass index (BMI) also keeping a close rela-
tion with TNF-a where mean TNF-a was increasing noticeably
corresponding to increase of BMI (P = 0.024).
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Prevalence of bmi and its related factors among
primary school students in Sanandaj, Iran
K MORADI
Islamic Azad University, Sanandaj, Kurdistan
Introduction and Objectives: Over the past 3–2 decades, the preva-
lence of obesity among children has been increased significantly. The
aim if this study was to assess the prevalence of BMI and its related
factors among primary school students in Sanandaj, Iran in 1389.
Methods: This research was a descriptive - analytical study. The
population included the primary school students in Sanandaj, who
selected by random cluster sampling (800 samples -400 girls and
400 boys). At first, their height and weight measured and secondly
their BMI calculated. Moreover, a questionnaire about BMI related
factors were completed by the respondents. After calculating BMI
and determining the values of the top percentile and the values
between 85 and 95 percentiles in proportion to the respective age
and gender, obese, overweight and low weight students were deter-
mined. Data analyzed by SPSS software using of CHISQURE and
Man-Whitney U Test.
Results: Prevalence of overweight and obesity in this study were
1.6% and 16.3%, respectively. Only, 23% of the students had normal
weight. There was a significant difference in obesity by students’ age,
duration of walking to school, and students’ appearance. Also, signifi-
cant differences were found in obesity by the number of hours watch-
ing television per day, entertainment type, place of living, parents’
education and job.
Conclusion: Unfortunately, the prevalence of childhood obesity in
our country is high. Considering this high (16.3%) prevalence of obe-
sity in this study and similar studies in the country and also its asso-
ciated factors such as duration of walking to school, the number of
hours watching television per day, entertainment type and place of
living, designing more appropriate interventions is suggested.
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BMI in lean and waist circumference in
overweight/obese subjects are the main
determinants of insulin resistance in a migrant
Indian population
NH NARAN, NJ CROWTHER
National Health Laboratory Services and the School of
Pathology of the University of the Witwatersrand,
Johannesburg, South Africa
Introduction: The principal anthropometric determinant of insulin
resistance is thought to be visceral adipose tissue mass. When
matched for BMI, this fat depot is known to be larger in subjects of
Indian ancestry compared to those of European ancestry. The size of
the visceral adipose tissue depot increases in parallel with rising BMI.
The aim of this study was therefore to determine whether a proxy
measure of visceral adipose mass, waist circumference, has a stronger
influence on insulin resistance in overweight and obese than lean
Indian subjects.
Methods: A convenience sample of 243 non-diabetic Indian
subjects resident in Johannesburg were recruited into the study.
Anthropometric and biochemical parameters were recorded. Insulin
resistance was calculated using the HOMA model and the relation-
ship between insulin resistance and anthropometric variables was
determined.
Results: In the total cohort, HOMA correlated with BMI (beta =
0.41, P < 0.0001) independently of waist circumference (beta =
0.28, P < 0.003). In lean subjects BMI (beta = 0.31, P = 0.0001)
was the principal determinant of HOMA whilst in overweight/obese
subjects, waist circumference (beta = 0.30, P = 0.003) was the
strongest correlate of insulin resistance.
Conclusion: This study demonstrates that in lean Indian subjects BMI
is the major determinant of insulin resistance whilst in overweight
and obese subjects waist circumference predominates. Thus, when
examining the relationship between anthropometric variables and
insulin resistance lean, overweight and obese subject groups should
be examined separately. In studies where such groups are combined,
the relationship between simple anthropometric measurements and
insulin resistance will be influenced by the ratio of lean: overweight:
obese individuals.
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Surveying size of neck circumference of higher
standard and its relation with hyperglycemia in
the patient suffering from coronary artery
disease in the hospitals affiliated with Tehran
city Universities of Medical Sciences in 2010
academic year
S NASROLLAH1, SA JALAL MANESH2, S MOHAMMAD
ZADEH2, M MAHMOODY3
1Medical-Surgical Nursing Department, Faculty of Nursing and
Midwifery, Islamic Azad University of Medical Sciences, Tehran
Branch, Tehran, Iran; 2Faculty of Nursing and Midwifery,
Islamic Azad University of Medical Sciences, Tehran Branch,
Tehran, Iran; 3School of Health, Tehran University of Medical
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Introduction: The most prevalent coronary disease is coronary artery
disease that is lead to death, disability and economic costs more than
any other disease and prevalent of risk factors of this disease is
increased rapidly worldwide. Hyperglycemia is one of the risk factors
of this disease. General objective of this research is determining size
of neck circumference of higher standard and its relation with Hyper-
glycemia in the patient suffering from coronary artery disease.
Methods: Present research is a descriptive-analytical study. 200
women and 200 men were selected by Poisson sampling method.
Data were collected by an interview and documentation form in 2
parts: Demographics and clinical examination (fasting blood sugar,
neck circumference). This form were filled out through interview
with patients and measurement of the researcher.
Results: It revealed that 85% of men and 84/4% of women under
study bear of higher standard neck circumference and there were a
significant relation (P < 0.05) between the size of higher standard
neck with fasting blood sugar (FBS) of patients (men and women)
suffering from coronary artery disease. Also a significant relation
(P < 0.05) were seen between those having a higher standard neck
size with hyperglycemia in control of their individualized factors like
age, job, education, records of higher blood sugar, consumption of
blood sugar reducing pharmaceuticals, consumption of insulin, and
blood sugar suffering duration.
Conclusion: With respect to the relationship between higher-standard
neck and hyperglycemia in people with coronary artery disease,
providing appropriate educational programs in this regard is
suggested.
P56
Evaluation of sudomotor function as a screening
tool for diabetes
B ONGPHIPHADHANAKUL1, C NGAKUMOS1,
P TENGPRATTANAKOM1, P BRUNSWICK2,
JH CALVET2
1Ramathibodi Hospital, Bangkok, Thailand; 2Impeto Medical,
Paris, France
Objective: Early detection may reduce the burden of diabetes and its
complications. The aim of this study was to evaluate the utility in the
screening of diabetes of EZSCAN, a new non-invasive device devel-
oped for a quick and quantitative evaluation of sudomotor function
whose disturbance begins in prediabetes.
Methods: One hundred and twenty five Thai subjects at high risk of
diabetes were involved in the study. Each subject underwent an oral
glucose tolerance test. A repeated test was performed if the initial
test showed either impaired glucose tolerance or diabetes. EZSCAN
was performed in all subjects on the day of the initial oral glucose tol-
erance test. According to EZSCAN, subjects were classified as
green = no disturbance, yellow = intermediate disturbance and
orange–red = high disturbance). Cut-off point for diabetes was 2 h
plasma glucose ‡200 mg/dL.
Results: Based on two positive tests 5 subjects were classified as dia-
betes. When using EZSCAN’s orange-red group as the category for
positive test, EZSCAN had a sensitivity of 100% and a specificity of
43.3% to detect diabetes while they were 60% and 100% respec-
tively for FPG. Of all the subjects whose EZSCAN results were nega-
tive (green, n = 52), none had diabetes based on 2 positive oral
glucose tolerance tests.
Conclusion: Assessment of sudomotor function by EZSCAN appears
to be a sensitive method to rule out diabetes or impaired glucose tol-
erance in asymptomatic subjects before performing more specific but
less sensitive tests.
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Genetic polymorphisms of the visfatin gene and
its correlation with different metabolic
parameters in obese children
SQ OOI1, RME CHAN2, KS POH2, SU GAN3, KO LEE1,
YS LEE2
1Department of Medicine, Yong Loo Lin School of Medicine,
National University of Singapore, Republic of Singapore;
2Department of Paediatrics, Yong Loo Lin School of Medicine,
National University of Singapore, Republic of Singapore;
3Department of Surgery, Yong Loo Lin School of Medicine,
National University of Singapore, Republic of Singapore
Visfatin is a novel adipocytokine which was reported to be predomi-
nantly secreted by visceral adipose tissues and had insulin-mimetic
properties. Serum level of visfatin was reported to be associated with
insulin resistance and obesity. Some studies revealed associations
between variants of the visfatin gene and different metabolic para-
meters such as glucose and lipids. In this study, we aim to examine
the role of visfatin gene variants in the pathophysiology of obesity in
children. We genotyped the upstream promoter region, exon-intron
boundaries and 11 exons of the visfatin gene in 24 DNA samples of
local obese children through direct DNA sequencing. Two upstream
variants -3187G>A and -1537C>T in perfect linkage disequilibrium
were detected and the sequencing of the exons region of the visfatin
gene also identified synonymous variants +7849T>C at exon 2 and
+21426G>A at exon 7 respectively. Direct sequencing of specific
regions of interest with these variants was then performed in 222
other obese paediatric subjects of the same study cohort. The
upstream variants, -3187A/A and -1537T/Tof minor allele frequency
(MAF) of 0.451 were shown to correlate significantly with higher
level of triglycerides. In addition, the variants at exon 2, +7849T>C
(MAF = 0.033) and at exon 7, +21426G>A (MAF = 0.12) were
also found to be associated with fasting glucose level and birth-
weight respectively. The associations between the variants and meta-
bolic parameters remained significant (P < 0.05) after adjusting for
ethnicity. These findings indicate a possible contribution of visfatin
gene variants in the development of co-morbidities and cardio-meta-
bolic risk in childhood obesity.
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Exploring foot care education in diabetic
patients in Chantanburi, Thailand
S PARBOTEEAH1, T NAMWONG2, L RAFTER3
1De Montfort University, UK; 2De Montfort University, UK;
3Burton Hospitals NHS Trust, UK
There is a close relationship between foot care education in diabetic
patients and the development of foot ulcers, amputations and related
complications. The aim of this study was to explore what education
diabetic patients received in the management of their feet and what
advice and education practitioners provided. Data was collected from
15 patients, 5 educators and 5 practitioners using semi-structured
interviews in a District Hospital in the Province of Chantanburi in
Thailand. The findings indicate that only 36% of patients receiving
hospital treatment for diabetes understood their conditions and that
93% were aware of the complications associated with the disease.
Patients indicated that they had received foot care education. How-
ever, patients’ reports suggest that patients did not take sufficient pre-
ventive action such as daily foot examinations in order to avoid foot
complications. In appropriate foot care and foot wear were contribu-
tory factors in the development of foot complications. Both nurses
and educators showed poor knowledge in the management of gly-
caemia, foot care behaviours, nutrition, referral to doctors, blood
investigations, footwear, callus management, off loading and any
assessments to find patients’ needs.
In conclusion, although foot care education is given to diabetic
patients, it is sporadic. A more systematic and organised system of
foot care education should be developed supported by a robust audit
system for monitoring quality. The findings from this study influ-
enced the development of foot care guidelines using the Delphi Tech-
nique.
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Effect of therapeutic supplementation and life
style intervention in the management of
hypertension among smokers
R RANGANATHAN1, R GUNALAN1
1Avinashilingam Deemed University for Women, Coimbatore,
India
Hypertension is 21st century’s pandemic. It is a commonly occurring
disorder with a high degree of clinical, health and economic impor-
tance. Smoking is considered to be one of the main causative factors
contributing to hypertension. The study was planned with an objec-
tive to assess the role of Oats, Green gram and selected herbs in con-
trolling hypertension among smokers. One hundred and fifty
smokers working in an industry were selected and their blood pres-
sure, anthropometric measurements, their life style, habits, medical
history and dietary intakes etc were obtained through an interview
schedule. A subsample of 30 hypertensive smokers were selected for
the two groups namely experimental and control group. A porridge
consisting of 25 g of oats (avena sativa), 10 g of green gram (vigna
radiata), and 2 g of Agathi (sesbania grandiflora), Mint (menthe
arvensis), Tulsi (ocimum sanctum), Hibiscus (rosa sinesis), Curry
leaves (murraya koenigii) and 3 g of jaggary were given to experi-
mental group (n = 15) everyday for a period of 60 days. Along with
the supplementation, the subjects were also given training in yoga
and meditation. An educational package has been prepared to impart
knowledge to the subjects about the importance of diet, physical
activity, basic education on hypertension and its monitoring. Control
group (n = 15) did not receive any supplement. Blood pressure was
monitored before and after supplementation for both the groups and
the results show that there is a significant change (P < 0.01) in
systolic and diastolic blood pressure on the selected subjects of
experimental group after supplementation. Thus it can be
concluded that the supplementation and lifestyle intervention had a
significant impact on lowering blood pressure of hypertensive
smokers.
P60
Modeling of liver glucose metabolism outgoing
from positron emission tomography with
physiologically interpreted model parameters
Z RAUSOVA1, J CHRENOVA1, P NUUTILA2, P IOZZO3,
L DEDIK1
1Faculty of Mechanical Engineering, Slovak University of
Technology, Bratislava, Slovakia; 2Turku PET Centre, University
of Turku, Turku, Finland; 3Institute of Clinical Physiology,
National Research Council (CNR), Pisa, Italy
Aims: Our aims were to develop mathematical models, capable of
evaluating mechanisms within the liver and/or the whole-body blood
metabolism; to obtain novel information to the role of liver blood
flow and the other significant physiologically interpreted parameters;
to experimentally validate the constructed circulatory model using
the data from a pig trial and to simulate measured plasma tracer con-
centration-time profiles of the individuals enrolled; to find differ-
ences in physiologically interpreted parameters between the two
groups of pigs in a fasting state and in euglycemic supraphysiological
hyperinsulinemia.
Materials and Methods: The group of pigs in a fasting state and the
group of pigs with euglycemic supraphysiological hyperinsulinemia
were scanned by positron emission tomography after a single dose of
[18F] FDG tracer and at the same time frequent sampling was
obtained in carotid artery, portal vein and hepatic vein. Structural
mathematical models with physiologically interpreted parameters
were used. A system-approach was used to the liver and/or the
whole-body system by the tools of the linear dynamic system theory.
Results: Three kinds of structural models, single input and single out-
put or multiple outputs and multiple inputs and single output, were
verified. Differences between the group of fasting pigs and the group
of pigs in euglycemic supraphysiological hyperinsulinemia were
found from the view of the estimated parameters of the structural
models.
Conclusion: Suitability of the structural mathematical models for the
estimation of physiologically interpreted parameters from PET was
validated.
P61
Effects of 4 year testosterone treatment on
components of the metabolic syndrome
F SAAD1,2, A. HAIDER3, LJ GOOREN4
1Bayer Schering Pharma, Scientific Affairs Men’s Healthcare;
2Gulf Medical University School of Medicine, Ajman, UAE;
3Private Urology Praxis, Bremerhaven, Germany;
4Endocrinology, VUmc, Amsterdam, The Netherlands
Background: Elderly men often show a concurrence of a decline of
testosterone with features of the metabolic syndrome. This study
tested the effects of normalization of testosterone.
Materials and methods: 136 hypogonadal men (38–83 years, mean
60.6 ± 8.0 years), with testosterone levels between 0.14–4.51 ng/
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mL (n > 4.90 ng/mL) were treated with parenteral testosterone
undecanoate for 4 years as the sole intervention.
Results: Plasma testosterone rose from 3.3 ± 1.9 ng/mL to
4.1 ± 1.5 ng/mL (P < 0.01) at 3 months, then stabilized at
6.8 ± 1.3 ng/mL after the first 6 months. There was a remarkable
progressive linear decline of body weight, waist circumference, serum
cholesterol, triglycerides, LDL-cholesterol and C-reactive protein over
the 4 year period. Plasma glucose declined over the first 18 months.
There was a significant decrease of levels of aspartate aminotransfer-
ase (AST) and alanine aminotransferase (ALT) over the first
24 months, then values leveled off. Both systolic and diastolic blood
pressure decreased over the first 30 months. At baseline 52/136 met
the criteria of the metabolic syndrome as defined by the National
Cholesterol Education Program (2001); after 2 years of testosterone
treatment this number had declined to 12/136.
Conclusion: With testosterone treatment over 4 years, the most sig-
nificant improvement of the metabolic syndrome, including blood
pressure, was noted over the first 24 months but over the following
24 months improvements were at least maintained or even further
improvement was observed. Decreases in AST and ALT are likely to
indicate improvement of liver steatosis.
P62
Visual statistical analysis on results of HBA1c
as an effect of the diet bread consuming in
Prilep, Macedonia
Z SAVOSKI1, S SAVOSKA2, S LOSKOVSKA3
1General Hospital Prilep, Macedonia; 2Faculty of
Administration and Management of Information Systems,
UKLO Bitola, Macedonia; 3FEIT, UKIM Skopje, Macedonia
The aim of this study is to check how diet broad influence to people
with diabetes of the level of HbA1c.
In the project were participated 80 randomly picked volunteers,
from which 64 will consume diet bread and will measure level of the
blood sugar, and 8 volunteers will just measure level of the blood
sugar without consuming diet bread. The condition was: all volun-
teers to observe toward proposed directions for interim prescribed
diet and use and receive therapy proposed by a doctor. The volun-
teers were do measure of the blood level sugar twice a week.
The volunteers were separated in two bigger groups – insulin
dependent and non-dependent, but also in fifth groups by years. The
results are statistical processed and visually presented. During the
project, we have made an education about diabetes to all volunteers.
The education goes individually during measure of blood sugar level
and in groups during meetings. People exchange their experiences
and tell their opinions for the quality and amount of the diet
bread and about measured results of the blood sugar level. The aver-
age enhancement of HbA1c was 1.9%, in the volunteers who have
made just measuring just 0.9%. The best results was gained from
insulin non-dependent between 50–60 years–2.4% and the worst in
children just 0.7%. As a conclusion at this moment we may say that
consuming of diet bread decrease blood level sugar, but also a big
influence in this have an education of people with diabetes.
P63
The effects of pre-hypertension and diabetic
mellitus on myocardial infarction in Iranian
adults: a population base study
K SAYEHMIRI1, F AZIZ2
1Ilam University of Medical Sciences, Ilam, Iran; 2Research
Institute for Endocrine Sciences, Shahid Beheshti University
(M.C), Tehran, Iran
Object: To investigate the association of pre-hypertension and dia-
betic mellitus with the risk of myocardial infarction (MI) in man and
female 30 years and over.
Methods: In the TLGS cohort study included 5187 Iranian adults at
Tehran city aged 30 to 90 years at baseline. The mean duration of
follow up was 6.5 years. Analysis was done using Cox proportional
hazard regression and accelerated failure time models.
Results: The TGLS cohort had 83 MI. The annually incidences of MI
were 3.91/1000 for men and 1.58/1000 for women in the TGLS.
Prevalence of pre-hypertension (130<SBP<140 or 80<DBP<80)
was 35.7%. The age and sex adjusted relative risk of MI in patients
with pre-hypertension at baseline was1.1 (95% CI: .6to 2.1) times
compared with normal group (SBP<130, and DBP<80) so pre-
hypertension increase the risk of MI about 10%. The attribute risk
fraction for population (AFP) for SBP and DBP was 31.4% and
14.3% respectively.
The age and sex adjusted relative risk of MI in patients with
FBS>126 at baseline was 5.4(95% CI: 3.45 to 8.44) times compared
with FBS<126. Attribute risk fraction (AR) for exposed group
(FBS>126) was 85.4% and attribute risk fraction for population
(AFP) was 37.1.
Conclusions: Pre-hypertension and diabetic mellitus remains as an
important risk factor for MI in men and women aged 30 years and
older.
P64
Esophageal dysmotility is frequent in obese
patients with different stages of diabetes
mellitus
JH SCHNEIDER, WV PETERSEN, M KUEPER,
T MEILE, A KOENIGSRAINER
Department of General, Visceral, and Transplant Surgery,
Germany
Background: Obesity is characterized by excess body fat. In the
northern hemisphere the prevalence of overweight increased up to
34% and carries substantial co morbidities as diabetes mellitus
(DM). Esophageal dysmotility (ED) is well known in morbid obese
patients as well as in patients with DM. There are only a few studies
which addressed the prevalence of ED in this patient.
Methods: In prospective study data of 10 healthy volunteers (group
I) were compared with 30 morbid obese patients (BMI >40) without
DM in group II. In group III: 23 patients with short duration of DM
(<3 years) and in group VI: 31 patients with long extended time of
DM (7<years) were collected. In group V we measured 10 morbid
obese DM patients with severe comorbidities. Al participants under-
went a standardized esophageal manometry, ambulatory 24 h pH-
metry and a Multichannel Intraluminal Impedance (MII) investiga-
tion.
Results: In group II we measured significant more pathological
sequences of the esophagus compared to all other groups
(P < 0.03). The DeMeester Score showed in group II the highest
pathological value of acid reflux (P < 0.03). Obese patients in group
IV und V showed significant more acid and non-acid refluxepisodes
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compared to patients of group III (P < 0.02). In contradiction the
amount of refluxepisodes were significantly higher in the control
group (P < 0.0001).
Conclusion: Our study confirmed different esophageal and gastric
motility aberrations. Diminution masks some pathological findings of
the esophagus. In morbid obese patients with DM the DeMeester
Score is significantly increased in our series.
P65
Patients with different stages of morbid obesity
and gastroesophageal reflux measured by
intraluminal impedance
JH SCHNEIDER, WV PETERSEN, M KUEPER,
T MEILE, A KOENIGSRAINER
Department of General, Visceral, and Transplant Surgery,
Germany
Background: Obesity became one of the leading chronic diseases
throughout the world. The relationship of obesity and gastroesopha-
geal reflux disease (GERD) is incomplete understood. The purpose of
the study was to evaluate gastroesophageal reflux in patients of dif-
ferent stages of obesity.
Methods: 51 obese patients were enrolled in this study. Additional
16 healthy volunteers were as controls in group I collected. All obese
patients were divided into three subgroups according to their BMI.
All the participants underwent esophageal manometry, gastroscopy
and 24 h combined MII and 24 h pH-metry. The arrangement of sev-
eral segments of neighboured impedance electrodes allows detecting
a bolus presence at various levels and the direction of the bolus
movement. Statistics were performed with the conventional compu-
ter assistant JMP program.
Results: The prevalence of GERD in morbidly obese patients was
47%. Compared to the control group I the mean of esophageal con-
traction amplitudes differed significantly in all patient groups
(P < 0.005). The median LESP was significantly decreased in all sub-
groups (II-IV) (P < 0.001). The DeMeester score of obese patients
with GERD showed considerably significant higher values than the
normal weighted control group (P < 0.05). The ratio between the
frequencies of acid compared to non-acid reflux episodes were
approximately 2:1 in the groups II-IV. The proximal migration level
(15cm) of the acid reflux was in obese patients significantly higher
than in the control group (P < 0.05).
Conclusion: Patients with morbid obesity to developed GERD. But
GERD does not correlate directly with the degree of obesity.
P66
The effects of telmisartan on first-phase insulin
secretion in vitro in db/db mice
J SHAO, P GU, H DU, B LU
Department of Endocrinology, Nanjing General Hospital of
Nanjing Military Command, Nanjing, China
Objective: Several epidemiological studies suggested that treatment
with angiotensin II type 1 receptor blocker provided a risk reduction
of developing type 2 diabetes. Yet the mechanisms remain to be eluci-
dated. The aim of present study was to explore the effects of telmisar-
tan on first-phase insulin secretion of islets in vitro on db/db mice.
Methods: Eighteen db/misty mice, 8 weeks of age, were randomized
to three groups as A, B, and C with 6 mice in each group. Twelve
age-matched db/db mice were randomized to two groups as D and
E. After islet isolation, islets of A~E group were incubated and per-
fused with medium adding blank, 100 nmol /L AngU, 10ƒ?mol/L
telmisartan +100 nmol /L AngU, blank, and 10ƒ?mol/L telmisar-
tan respectively. The islets were stimulated in the continuous pre-
sence of a high concentration of 16.7 mmol/L glucose. Samples were
collected at multiple time points until 30 min after 16.7 mM glucose
solution perifusion for insulin measurement.
Results: First-phase insulin secretion of db/misty was significantly
impaired by AngII, with its peak only reached 4 times of basal level.
While telmisartan beforehand improved its secretion to 7 times of
basal level. First-phase insulin secretion of db/db was greatly dimin-
ished to a extent of lower than 3 ug/L, while telmisartan improved
its secretion to 6 ug/L.
Conclusions: By blocking local RAS, Telmisartan intervention remark-
ably improved first-phase insulin secretion of islets in vitro on db/db
mice, thus protected ƒ?-cell function. And this may contribute to the
mechanisms of its anti-diabetic benefits.
P67
Dual energy X-ray absorptiometry assessment
of bone mass, fat mass distribution in type 2
diabetes mellitus men
A SHEPELKEVICH1, E PLETNEVA1, V VADZIANAVA2,
N VASILIEVA2
1Belarusian State Medical University, Minsk, Belarus; 2Republic
Medical Rehabilitation and Balneotreatment Center, Minsk,
Belarus
Background and aims: The central distribution of body fat has been
identified as a significant risk factor for the development of cardio-
vascular disease. Determined parameters of metabolic syndrome and
fat distribution are important for the prevention of macrovascular
complications in type 2 diabetes mellitus (DM). Also several studies
indicated that DM is a risk factor for certain types of osteoporotic
fractures among adult people. The aim of the study: to assess BMD
and features of fat mass distribution in men with type 2 DM in com-
parison with nondiabetic men.
Materials and methods: 47 men with type 2 DM and 17 controls were
examined. The research involved DEXA with Body composition pro-
gram.
Results: BMD (g/sm2) was statistically lower in diabetic patients at
femoral neck (0,873 ± 0,151 vs 0,972 ± 0,161, P < 0.02) in com-
parison with controls. Fat mass distribution parameters in type 2 DM
men were: Total Body 31,35 ± 8,43% vs 27,45 ± 4,13%, P < 0.05;
Android: 40,5 ± 8,09% vs 37,10 ± 4,04%, P < 0.05; AG Ratio:
1,28 ± 0,21 vs 1,13 ± 0,14, P < 0.05; Trunk/Total: 0,63 ± 0,09 vs
0,57 ± 0,04, P < 0.05 in comparison with controls. (Arms + Legs)/
Total parameter was higher in nondiabetic patients than in type 2
DMmen (0,72 ± 0,18 vs 0,54 ± 0,21, P < 0.05).
Conclusion: The results of study revealed the prevalence of central
(android) distribution of body fat among men with type 2 DM in
comparison with nondiabetic patients. The data confirmed bone loss
manifestation in type 2 DMmen (predominantly at femoral neck).
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P68
Elevated expression and the function of FFAR2
in PBMCs from type 1 diabetic patients
G SHI1,2,3, W GU1,2,3, X ZHANG1,2,3, G NING1,2,3
1Shanghai Institute of Endocrine and Metabolic Diseases;
2Department of Endocrine and Metabolic Diseases; 3Shanghai
Clinical Center for Endocrine and Metabolic Diseases, Rui Jin
Hospital, Shanghai Jiaotong University School of Medicine
Objective: FTo study the expression and the regulatory mechanism of
FFAR2 in PBMCs from type 1 diabetic patients, and further study the
function of FFAR2 in diabetic mouse model.
Methods: F@PBMCs from recent onset type 1 diabetic patients and
healthy controls were collected, and the mRNA expression profiles
were analyzed by microarray; AHuman FFAR2 promoter region was
cloned and the transcription activity were analyzed in macrophage
cell line; BThe regulatory effect of FFAR2 on LPS or PMA induced
inflammation response and cell proliferation were analyzed; CMulti
low dose streptozocin induced diabetic mice were treated with
FFAR2 agonist, Sodium acetate, and diabetic indexes were analyzed
to investigate the protective effect of FFAR2 in this model.
Results: F@ The microarray result of PBMCs from 10 patients and
10 matched controls showed that FFAR2 mRNA increased by 4.9
fold; AThe promoter region of FFAR2 (-2266 to +48) was cloned
into pGL-luc plasmid; Our results showed that the promoter was acti-
vated by LPS and PMA stimulation in Raw264.7 macrophage cell
line; BActivation of FFAR2 by sodium acetate inhibits IL-6 mRNA
expression induced by LPS in Raw264.7 3T3-L1 adipocyte; Further,
Activation of FFAR2 by sodium acetate differently regulated cell pro-
liferation in different cell lines, such as Raw264.7, THP-1 and MCF-
7; CSodium acetate treatment in MLDS diabetic mice significantly
attenuated blood glucose and increased serum insulin compared with
untreated group under feeding state; Blood glucose was also signifi-
cantly lower after introperitoneal glucose challenge or insulin injec-
tion.
P69
Changes in distribution of abdominal adipose
tissue according to age in Korean men
KY SON, SJ KIM, HC CHOI, BL CHO
Department of Family Medicine, Seoul National University
Hospital, Seoul, South Korea
Background: The distribution of visceral adipose tissue (VAT) and
subcutaneous adipose tissue (SAT) is known to be related with age
and body mass index (BMI). However, whether the changes in VAT
and SAT distribution with BMI vary with age has not been studied.
Methods: We analyzed 6472 Korean men aged between 30 and 79
who underwent abdominal fat computed tomography (CT). We
examined the distribution of VATand SATacross BMI within the same
age group using regression models, and compared the degrees of
change in distribution patterns according to age groups using t-test.
Results: The VAT was positively associated with BMI increase in all
age groups (all P < 0.05), and a greater degree of VAT change was
observed with increasing age (30s, 10.9 ± 0.5; 40s, 12.4 ± 0.3; 50s,
13.4 ± 0.3; 60s, 14.2 ± 0.5; 70s, 16.1 ± 1.1; all P < 0.05). The
SATwas positively associated with BMI increase in all age groups (all
P < 0.05). The degree of increase in SAT decreased with age in age
groups of 30s, 40s and 50s (30s, 18.5 ± 0.4; 40s, 15.3 ± 0.3; 50s,
13.3 ± 0.3; all P < 0.05), but remained the same afterwards (60s,
13.1 ± 0.4; 70s, 13.9 ± 0.8; P > 0.05).
Conclusions: The VAT and SAT are both positively associated with
BMI, and the degrees of changes in the distribution of VAT and SAT
vary with age. The VAT increment with BMI consistently increases
with age. The SAT increment decreases until the 50s and remains
relatively constant afterwards.
P70
Waist to thigh ratio as a predictor of insulin
resistance: a cross-sectional study of Korean
women
KY SON2, SJ KIM1, JH PARK1, B CHO1
1Department of Family Medicine, Seoul National University
Hospital, Seoul, Korea; 2Center for Health Promotion, Seoul
National University Hospital, Seoul, Korea
Background: Insulin resistance is the strongest predictor of non-insu-
lin-dependent diabetes mellitus and visceral obesity is regarded as a
major cause. The purpose of this investigation is to ascertain if waist
to thigh ratio can be used as a reliable marker for insulin resistance.
Methods: The subjects of this cross sectional study were 95 women
above 20 years old who visited a university hospital obesity center
between December 2009 and June 2010. History taking and anthro-
pometric measurements were conducted by a single trained physi-
cian. Insulin resistance is defined as HOMA-IR above 3.04.
Results: Median age of total participants was 37.43 + 11.45 years.
HOMA-IR showed a positive correlation with body weight, BMI,
hypertension, waist circumference, waist to thigh ratio, triglyceride
and LDL cholesterol while showing a negative correlation with HDL
cholesterol by the Spearman’s rank correlation analysis. A simple lin-
ear regression analysis showed a positive correlation between waist
to thigh ratio and log-transformed HOMA-IR (R2:0.07, P < 0.01).
Waist to thigh ratio proved to be the most useful marker for the
detection of insulin resistance showing AUC 0.70 ± 0.55
(P < 0.005) by the ROC curve when compared with other tradi-
tional index such as BMI, waist circumference and waist to hip ratio.
The ROC curve demonstrated that the optimal waist to thigh ratio
for discriminating insulin resistance was 1.46 (sensitivity: 80.0%,
specificity: 51.4%) (P < 0.001).
Conclusion: There is a positive association between waist to thigh
ratio and HOMA-IR. Waist to thigh ratio is a useful and reliable mar-
ker for the detection of insulin resistance.
P71
The effects of video game based virtual reality
balance exercise on balance and functional
ambulation activities in older adults with
diabetic neuropathy
CH SONG, KJ LEE
Department of Physical Therapy, Sahmyook University, Seoul,
Korea
This study investigated the effects of a video game based virtual rea-
lity balance exercise (VRBE) on balance and functional ambulation
activities in older adults with diabetic neuropathy. 62 diabetic
patients with signs and symptoms of peripheral neuropathy were
enrolled, randomized and subdivided in two groups: a trained group
of 32 diabetic participants (75.43 ± 7.21 years old), and a control
group of 30 diabetic participants (74.87 ± 3.24 years old). The
trained group practiced a VRBE, using video game (eye toys, Sony,
Japan), for 60 min, two times a week for 8 weeks. Results were eval-
uated by both balance (postural sway path, Berg balance scale, func-
tional reach) and functional ambulation activities (Timed Up and Go
test, gait velocity). The results showed that postural sway path signif-
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icantly decreased (P < .05), Berg balance scale, functional reach,
improved significantly after VRBE (P < .05). Functional ambulation
activities from timed up and go test, and 10m walking time improved
significantly after VRBE (P < .05) In conclusion, the VRBE improved
balance and functional ambulation activities. These results suggested
that a VRBE is suitable for older adults with diabetic neuropathy.
P72
Prevention of obesity and hepatic insulin
resistance by vagotomy
Q SU, C BAKER, M DEKKER, K ADELI
University of Toronto
Perturbations in lipid metabolism are intricately involved in the
pathogenesis of obesity and type II diabetes. The gut-brain-liver neu-
ronal axis via the vagus nerve is a two-way highway of communica-
tion between the central nervous system and peripheral tissues/
organs that regulates many aspects of food intake and energy meta-
bolism. Clinically, complete disruption of abdominal vagus nerve
fibers has consistently abrogated weight gain or caused weight loss
in the treated subjects. The present investigation sought to under-
stand the molecular mechanisms underlying prevention of metabolic
syndrome by vagotomy. Sub-diaphragmatic vagotomy of mice, in
which both hepatic and gastric divisions of the vagal nerve were dis-
rupted, led to significant decreases in both hepatic and plasma levels
of triglyceride and apolipoprotein B compared to sham-surgery con-
trols. In addition, the population of very low density lipoprotein par-
ticles was greatly reduced by vagotomy. By subjecting both
vagotomized and sham mice to a high fat, high cholesterol (HFC)
diet, we found that vagotomy protected mice against weight gain
and hepatic insulin resistance induced by the HFC diet. Mechanistic
studies revealed that mRNA levels of hepatic stearoyl CoA desatur-
ase-1, which catalyzes the synthesis of oleyl CoA from stearolyl CoA,
were dramatically decreased in the vagal-nerve-disrupted mice.
Furthermore, increased secretion of the gut hormone, glucagon-like
peptide-1, may contribute to maintenance of insulin sensitivity in
vagotomized mice fed the HFC diet. These findings reveal a strong
link between the vagal nervous system and gut hormones in main-
taining metabolic homeostasis and preventing chronic disease
induced by high-fat and/or high-carbohydrate diets.
P73
Study sexual dysfunction in women with
diabetes and its impact on sexual satisfaction
and their satisfaction with life
F TAIRI, A GHARANFOLY
Kurdistan University of Medical Science
Introduction: Diabetes epidemic or off, a major global health pro-
blem that its incidence during the past risen dramatically and further
physical health, the impact on mental health Puts. Diabetes in
women with decreased libido, reaching orgasm or called orgasm,
decreased sexual arousal, pain and infections near the vagina is asso-
ciated with sexual side effects of diabetes disregarding the life of the
individual in long-term marriage with serious risks facing the hive
intimacy and comfort of man and woman is stripping and sexual
satisfaction and life satisfaction affects women negative effects of this
study to examine sexual dysfunction in women with diabetes and its
impact on sexual satisfaction and their satisfaction with life in the city
of Sanandaj deals.
Methods: This descriptive analysis of 100 cases of women with dia-
betes who were disposed to cooperate with the completed question-
naire to make based on DSM IV-R questionnaire marital satisfaction
(ENRICH), and interviews, the information they collect and SPSS
software were analyzed.
Results: The most common age adolescence (25 to 40 years) with a
frequency of 60%, illiterate, 30%, housewives, 62% and 74% resid-
ing townspeople60% of patients some degree of depression (mild,
moderate, severe) have sexual dysfunction in studied women with
decreased libido 57%, difficulty reaching orgasm (orgasm) 51%,
38% decreased sexual arousal, and pain is near 21%. between type 1
diabetes to depression and sexual dysfunction is a significant rela-
tionship between women with life satisfaction and sexual satisfaction
are significantly related sexual dysfunction.
Conclusion: Diabetes in women with depression, sexual satisfaction
and life satisfaction is their close relationship.
P74
Vietnamese diabetes self management program
T THAI
Western Region Health Centre, Victoria, Australia
Introduction: The Vietnamese Community has a low awareness of
diabetes. Family support in managing diabetes is found to be para-
mount in the Vietnamese community. Verbal information is the pre-
ferred method of education as literacy levels are low in the elderly.
The greatest barrier to the provision of diabetes services for this com-
munity is seen as language.
Aim: To provide information about Type 2 Diabetes; to increase
knowledge of condition; to increase self management skills; to
encourage lifestyle changes and improve an individual’s health; to
increase exercise tolerance; and to establish social links, support net-
works, and activity options in the local community.
Method: A 12 week program, comprising 1 h of group education,
30 min of discussion and review, and 30 min of exercise per week.
The program is conducted by a Vietnamese Diabetes Nurse Educator
(DNE) and other health professionals within the Community Health
Centre. Each client receives a program outline, and a Type 2 Diabetes
Education Booklet in Vietnamese edited by the DNE. The program is
evaluated using the Flinders University Chronic Condition Self Man-
agement tools that include the Diabetes Risk Calculator and the Part-
ner In Health (PIH) scale a Self Evaluation Questionnaire is also
administered.
Results: Scores from the PIH scale and results of HbA1c have
improved overall. The Type 2 Diabetes Education Booklet is useful
and informative.
Conclusion: Learning as a group increased participants’ knowledge of
Type 2 diabetes, self management skills, and exercise tolerance. The
program has encouraged lifestyle changes and improved individual’s
health; also establishing social links, support networks, and physical
activity opportunities in local community.
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Gynostemma pentaphyllum extract improves
insulin sensitivity in type 2 diabetic patients
HTT VU1,2,3, PV DAO2, T PHAM3, HK NGUYEN4,
CG OSTENSON1
1Department of Molecular Medicine and Surgery, Karolinska
Institutet, Stockholm, Sweden; 2Department of Internal
Medicine, Hanoi Medical University, Hanoi, Vietnam;
3Department of Endocrinology and Diabetes, National Institute
of Gerontology, Hanoi, Vietnam; 4Department of Internal
Medicine, University of Manitoba, Winnipeg, Manitoba,
Canada
Aims: To evaluate the effect of the traditional Vietnamese herb
Gynostemma pentaphyllum (GP) extract on insulin sensitivity in
drug-na?ve type 2 diabetic patients.
Methods: Sixteen patients completed the randomized, double-blind,
placebo-controlled crossover clinical trial. Patients received GP or pla-
cebo extract 6 g daily for 4 weeks and vice versa with a 2 week
washout period. At the end of each period, a Somatostatin-Insulin-
Glucose Infusion Test (SIGIT) was performed. Fasting plasma glucose
(FPG), HbA1C, oral glucose tolerance tests and insulin levels were
measured before, during and after the treatment.
Results: FPG and steady-state plasma glucose (SIGIT mean) were
lower after GP treatment compared to placebo treatment
(P < 0.001). The levels of FPG in the control group were slightly
reduced 0.2 ± 1.5 vs. 1.9 ± 1.0 mmol/L in GP group (P < 0.001)
and the effect on FPG was reversed after exchanging treatment. The
glycometabolic improvements were achieved without any major
change of circulating insulin levels. There were no changes in lipids,
body measurements, blood pressure and no reported hypoglycemias,
or acute adverse effects regarding kidney and liver parameters.
Conclusion: The results of this study clearly demonstrated that
the GP extract exerted anti-diabetic effect by improving insulin sensi-
tivity. The safety of GP extract was again proved clinically in the
trial. This study is registered at ClinicalTrial.gov with ID:
NCT01254084.
P76
IL-6 induces mitochondrial biogenesis in rodent
white adipose tissue
Z WAN1, C CHAN1, D WRIGHT2
1Alberta Diabetes Institute, University of Alberta, Edmonton,
Canada; 2Department of Human Health and Nutritional
Sciences, University of Guelph, Guelph, Canada
Thiazolidinediones (TZDs) are a commonly prescribed class of
anti-diabetic medications that appear to mediate their beneficial
effects, at least in part, through the induction of adipose tissue
mitochondrial biogenesis. Owing to the deleterious side effects of
TZDs, the identification of alternative approaches to induce adi-
pose tissue mitochondrial content is needed. It has been demon-
strated that exercise induces adipose tissue mitochondrial
biogenesis, however the hormonal factors for mediating these pro-
cesses remain unidentified. Interleukin 6 (IL-6) is markedly
enhanced during exercise. Thus, we hypothesized that IL-6
secreted from adipose tissue during exercise will increase mito-
chondrial biogenesis in white adipose tissue. An acute bout of
exercise robustly increased the phosphorylation of signal transdu-
cer and activator of transcription 3 (STAT3), a signaling intermedi-
ate activated by IL-6 in adipose tissue. Similarly, exercise increased
the mRNA expression of suppressor of cytokine signaling 3
(SOCS-3) in adipose tissue, a transcriptional target of IL-6. Treat-
ment of culture adipose tissue with IL-6 (75, 150 ng/mL) for 6 h
led to approximately 2 and 3 fold increases in mRNA expression
of peroxisome proliferator activated receptor co-activator 1-alpha
(PGC-1a) respectively, a master regulator of mitochondrial biogen-
esis. To assess more directly the effects of IL-6 on adipose tissue
mitochondria biogenesis, markers of mitochondrial biogenesis were
measured in white adipose tissue from IL-6 knockout (IL-6-/-)
mice. Citrate synthase activity and the protein content of succi-
nate-ubiquinone oxidoreductase (SUO), cytochrome c oxidort.t.tase
core I subunit (CORE1) and heat shock protein-60 (HSP60) were
reduced from IL-6-/- mice. In conclusion, exercise induced adipose
tissue mitochondrial biogenesis may be regulated by IL-6.
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Serum total cholesterol is independently,
inversely associated mortality risk in very old
hospitalized patients
A WEISS1, Y BELOOSESKY1, MM BOAZ1,2
1Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
2Department of Nutrition, School of Health Sciences, Ariel
University Center, Ariel, Israel
Background: In a previous report, we showed that BMI was signifi-
cantly, inversely associated with risk of death. This inverse associa-
tion between BMI and mortality may represent a protective
metabolic ‘‘reserve’’ during periods of stress. Total cholesterol has
been identified as a measure of nutriture and is inversely associated
with mortality in hemodialysis subjects. We therefore examined
whether increased total cholesterol reduced mortality risk in very old
hospitalized patients.
Methods: A total of 477 inpatients (226 males), mean age of
81.5 ± 7 years, hospitalized in an acute geriatric ward between
1999 and 2000 were included in the study. Serum total cholesterol
was measured on admission day in the framework of usual care.
Patients were followed until August 31, 2004. Mortality data were
extracted from death certificates.
Results: During a follow-up of 3.47 ± 1.87 years, 248 patients died.
Those who died had significantly lower baseline serum total choles-
terol than those who survived (182.5 ± 45.8 vs. 201.9 ± 39.6 mg/
dL, P = 0.005). Serum total cholesterol was significantly, inversely
associated with all cause mortality even after controlling for age, sex,
diabetes, renal failure and BMI (HR 0.996, 95% CI 0.993–0.999,
P = 0.009), indicating that each 1 mg/dL increase in serum total
cholesterol was associated with a 0.04% decrease in risk of death.
HR estimates for serum total cholesterol were unchanged when the
analysis was restricted to the subset of patients (n = 435) who sur-
vived for at least 6 months.
Conclusions: In very elderly subjects, increased serum total choles-
terol was associated with reduced mortality risk.
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The role of SIK1 in diabetes with hypertension
X WEN, Q LIAO, W XU, J YU, K LU
Liyuan Hospital, Tongji Medical College, Huazhong University
of Science and Technology
Objectives: Diabetes usually accompany with hypertension, which is
relevant with the enhanced sodium reabsorption in renal tubular.
Newly discovered salt-induced kinase 1 (SIK1) not only involved in
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glucose and lipid metabolism, but also activated Na+, K+-ATPase
activity through signaling pathways, leading to high blood pressure.
SIK1 activity was significantly elevated in renal proximal tubule cells
from Milan hypertensive rats. However, whether SIK1 is expressed in
the kidney of diabetic rats has not evaluated yet. This study investi-
gates the abundance of the renal SIK1 and Na+, K+-ATPase a1 mRNA
and protein, as well as the activity of Na+, K+-ATPase in experimen-
tal diabetic rats, and also analyzes the role of SIK1 in diabetes with
hypertension.
Methods: Male Wistar rats were randomly divided into three groups:
normal group, type 1 dibetic(DM1) group,and type 2 diabetic(DM2)
group(n = 12 in each group). Rats in normal and DM1 groups were
fed regular chow, and rats in DM2 group fed high-fat diet. After
4 weeks, rats received STZ of 60 mg/kg and 30 mg/kg body weight
intraperitoneally in DM1 and DM2 group respectively. Metabolic
parameters and renal functionweremeasured. Tail arterial blood pres-
sure was checked. Kidney stained with HE and PAS were examined
by light microscope. The level of mRNA and protein expression of
SIK1 and Na+, K+-ATPase a1 in renal tissue were detected by RT-PCR
and Western blot. Meanwhile Na+, K+-ATPase activity were
measured.
Results: Compared with normal group, fasting blood glucose, insulin,
total cholesterol and triglycerides were increased markedly
(P < 0.01).Serum creatinine, urea nitrogen, and urine albumin were
significantly increased in the rats of two model groups (P < 0.01).
Insulin sensitivity index decreased significantly in the diabetic rats
(P < 0.01). Blood pressure in two model groups was significantly
higher than normal (P < 0.01). Light microscopic examination
showed markedly increased glomerular area and mesangial region,
thickened glomerular basement membrane, swollen renal tubular
epithelial cells, narrowed lumina in two model groups. The expres-
sion levels of SIK1 and Na+, K+-ATPase a1 mRNA and protein were
significantly increased in diabetic rats(P < 0.01). Na+, K+-ATPase
activity was significantly increased in two model groups compared
with normal group (P < 0.01).All of the above results between the
two model groups was not significant different.
Conclusion: SIK1 mRNA expression and protein level increased in
DM1 and DM2 rats. At the same time, mRNA and protein of Na+,
K+-ATPase a1 were up-regulated in both DM1 and DM2 rats. Na+,
K+-ATPase was over-activated. Rats in both model groups showed a
characteristic pathological changes of diabetic nephropathy and
hypertension. SIK1 itself or via regulating Na+, K+-ATPase involved
in the process of diabetic nephropathy accompanied with hyperten-
sion in DM1 and DM2 rat. This work was supported by National Nat-
ural Science Foundation of China (No.30672730).
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Trigonella foenum graecum seed extract
protects against functional and morphological
abnormalities in kidneys of diabetic rats via its
antioxidant activity
W XUE
Department of Public Health, Xi’an Jiaotong University School
of Medicine
Oxidative stress is involved in the development and progression of
diabetic nephropathy (DN). Because Trigonella foenum graecum has
been reported to have antidiabetic and anti-oxidative effects, we
hypothesized that Trigonella foenum graecum seeds aqueous extract
(TE) restores kidney injuries of diabetic rats via its antioxidant activ-
ity. Rats were fed diets enriched with sucrose (50%, w/w), lard
(30%, w/w) and cholesterol (2.5%, w/w) for 8 weeks to induce
insulin resistance. After a DN model was induced by streptozotocin,
the rats were administered a low (440 mg/kg), medium (870 mg/
kg) or high (1740 mg/kg) dose of TE by oral intragastric intubation
for 6 weeks. In TE-treated DN rats, blood glucose, kidney/body
weight ratio, serum creatinine, blood urea nitrogen, 24 h content of
urinary protein and creatinine clearance were significantly decreased
compared to non-treated DN rats. Diabetic rats showed decreased
activities of superoxide dismutase and catalase, increased concentra-
tions of malondialdehyde in the serum and kidney, and increased
levels of 8-hydroxy-2 Œ- deoxyguanosine in urine and renal cortex
DNA. Treatment with TE restored the altered parameters in a dose-
dependent manner. Furthermore, all the ultramorphological abnorm-
alities in the kidney of diabetic rats, including the uneven thickening
of the glomerular base membrane, were markedly ameliorated by TE
treatment. We conclude that TE confers protection against functional
and morphological injuries in kidneys of diabetic rats by increasing
activities of antioxidants and inhibiting accumulation of oxidized
DNA in the kidney, suggesting a potential drug for the prevention
and therapy of DN.
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A study of % body fat and other health related
variables due to exercise & drinking habits on
pre & post-menopause of female
JH YOO
Sahmyook University, Seoul, Korea
Lack of physical activity has been shown to play a major role in gain-
ing body fat. conversely, regular exercise is an important factor in pro-
moting the loss of body fat. Most world population consume
alcoholic beverages. However, alcohol may have both protective and
harmful effects on health. The purpose of the this study was to exam-
ine the comparison of % body fat and other health related variables
due to exercise & drinking habits on pre and post-menopause of
female. Using a cross-sectional approach, we studied 508 women
(respectively, pre menopausal 215, post menopausal 293). Subjects
were divided into 3 groups depended on exercise habit (sedentary,
exercise less than twice a week and more than three time a week)
also, 2 groups depended on drinking habit(not drink and drink less
than twice a week), respectively. We measured % body fat and other
health related fitness included bone mineral density. Measured other
health related physical fitness include % of body fat, maximum oxy-
gen consumption, grip strength, sit & reach, reaction time and closed
one leg stand. In pre-menopause, exclude sit & reach, physical fitness
and bone mineral density showed no significant difference among
the exercise habits. Also, comparing with the non-drinkers, the drin-
kers had no significant differences in bone mineral density and physi-
cal fitness levels. In post-menopause, % of body fat and bone mineral
density showed significant differences among the exercise habits.
Also, bone mineral density of drinkers showed a higher tendency
than non-drinkers, but physical fitness had no significant differences
between the groups.
P81
Comparison of elderly diabetic lifestyle in
Sanandaj with standards
M ZAREI, F BIDAPOOR, F GHARIBI
Kurdistan University of Medical Science, Sanandaj, Iran
Background: This study compared lifestyle of diabetic elderly
patients with standard lifestyles.
Methods: This cross-sectional study of 250 elderly diabetic that was
chosen performed by cluster sampling method. Information based on
questionnaires.
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Results: Results showed that the average age in the diabetic elderly
patients was 66 years. in the study population, 138 patients (55/
2%) were female and 62 patients (44/8%) were men, none of them
has standard precision food consumption(75/5 percent lower than
standards AND 24/5 percent more than standards) And 31/2 percent
of them had a good exercise (78/2 percent was walking exercise and
1.28 percent were cycling.) 87 patients (34/8%) was Glucose control
according to their program. only 20 patients (8%) of regular blood
glucose control had done.
Conclusion: This study showed that the quality of life for elderly peo-
ple with diabetes who living in the Sanandaj City in comparison with
appropriate standards is inconsistent and we have been plan to dia-
betes control, especially in countries where aging populations will
increase in future.
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Alternative therapy of arterial hypertension with
prestarium in old patients with diabetes
mellitus, type II and nephropathy (polymorbidy
syndrome)
R ZASLAVSKAYA, SV SERGEEV
Hospital N60, Russia
Aim: To study different approaches to treatment with prestarium
(Servie, France) of old pts with arterial hypertension (AH) together
with polymorbidy syndrome (PS).
Material and methods: 60 pts (mean age – 73 years old) with AH
together with diabetes mellitus, type II, adipositas, nephropaty, dislipi-
demia, were divided into three groups with 20 pts in each. The 1st
group received prestarium (P) (tert-butilamine salt) in a dose of 4 mg
twice a day. The second group received prestariumA (PA) (arginin salt)
in a dose of 5 mg once a day, in the chronotherapy (CT) regimen (4 h
before BP increased by BP-monitoring data with taking into account
pharmacokinekics). The 3-rd group obtained PA in the morning and
melaxen (melatonin, Unipharm, USA) in a dose of 3 mg at 22.00.
Before and after all types of therapy during 21 days pts were investi-
gated by clinic-laboratory examination, ECG, BP-monitoring, EchoCG.
Results: All methods of therapy produced antihypertensive effect (on
the 4 day) statistically significant. But circadian profile changed bet-
ter in (CT) with PA and with therapy of PA together with melaxen.
Daily and course doses of PA in regimen CTwere smaller, than of pre-
starium (tert-butilamine salt). Circadian profile of BP in pts with non-
dipper transfered in dipper. The same data was in therapy with com-
bination PA together with melaxen. Circadian organization of BP
rhythm normalized. Traditional therapy with prestarium (tert butila-
mine salt) did not make this effect. Levels of glucose, insulin, creati-
nin, urea in blood did not changed.
Conclusion: Treatment with prestarium A in chronotherapy regimen
and this drug with melaxen in old pts with AH and polymorbidy syn-
drome is more effective than traditional therapy with prestarium (tert
butilamine salt).
P83
Association of CIDEA and CIDEB gene with
obesity among Han Chinese
L ZHANG, J WU, J ZHANG, Y DAI, L BIAN,
W WANG
Department of Epidemiology and Biostatistics, School of Public
Health and Family Medicine, Capital Medical University,
Beijing, China
Objective: To assess the association of the SNPs of CIDEA and CIDEB
gene and the haplotype structure of CIDEA gene with obesity.
Material and methods: A sample of 347 subjects was included in a
case-control study for genotyping. Blood samples of subjects and
anthropometric measurements were collected. SPSS 13.0, Haploview
4.0 and Multifactor Dimensionality Reduction (MDR) software were
used for statistical analysis.
Results: The rs4796955 (G/T) and rs8092502 (C/T) polymorphisms
in CIDEA gene were associated with obesity [odds ratio (OR), 1.640;
95% confidence interval (95%CI), 1.206–2.232.829; and OR, 0.971;
95%CI, 0.666–1.415, respectively]. There was no significant differ-
ence in the allelic and genotypic frequencies of the rs34740317,
rs1053648 and rs3742509 polymorphisms in CIDEB gene between
the two groups. Haplotype GTTGC and TTTGC in CIDEA gene were
significant different between obesity and normal groups [OR, 1.612;
95%CI, 1.017–2.555.829; and OR, 0.478; 95%CI, 0.241–0.946,
respectively]. By MDR analysis, the best model was a four-locus site
model composed of SNPs rs45619832, rs4796955, rs8092502, and
rs12962340 in the CIDEA gene.
Conclusion: No significant result of CIDEB gene was obtained in our
study. The CIDEA genotypes were associated with obesity in Chinese
Han Population. G allele of rs4796955 and T allele of rs8092502
were a risk factor for obesity. The strong interaction between
rs45619832, rs4796955, rs8092502, and rs12962340 could increase
the risk of obesity significantly. The multiplicative effect of the CIDEA
genotype on obesity should be taken more attention in further
researches.
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